{
  "name": "Aera assistant",
  "nodes": [
    {
      "parameters": {
        "jsCode": "return $('Input data').all().map(x => {\n  const item = x.json;\n  let patientAnamnesis = '';\n\n  if (item.patientProfile) {\n    patientAnamnesis += `\n      # Patient profile\n\n      ${item.patientProfile}\n\n      ---\n      \n    `;\n  }\n  \n  if (item.bloodResultsData) {\n    patientAnamnesis += `\n      # Blood test results\n    \n      ${JSON.stringify(item.bloodResultsData)}\n\n      ${!!patientAnamnesis ? '---' : ''}\n      \n    `;\n  }\n\n  if (item.questionnaireResultsData) {\n    patientAnamnesis += `\n      # Questionnaire results\n\n      ${JSON.stringify(item.questionnaireResultsData)}\n      \n      ${!!patientAnamnesis ? '---' : ''}\n      \n    `;\n  }\n  \n  return {\n    anamnesis: patientAnamnesis.trim()\n  };\n});"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        780,
        100
      ],
      "id": "4b6dc917-de68-4d34-8cf3-ca5b383b336f",
      "name": "Generate patient anamnesis"
    },
    {
      "parameters": {
        "authentication": "serviceAccount",
        "resource": "fileFolder",
        "queryString": "={{ $('Input data').first().json.pathwayUrl }}",
        "limit": 1,
        "filter": {
          "folderId": {
            "__rl": true,
            "value": "13gNzGBlb92BhyBQ10pcx1w6D0PJqqVXq",
            "mode": "list",
            "cachedResultName": "health-plans",
            "cachedResultUrl": "https://drive.google.com/drive/folders/13gNzGBlb92BhyBQ10pcx1w6D0PJqqVXq"
          }
        },
        "options": {}
      },
      "type": "n8n-nodes-base.googleDrive",
      "typeVersion": 3,
      "position": [
        1020,
        100
      ],
      "id": "4cbfe618-a690-4157-a112-97b2dbacb665",
      "name": "Search Health Plan Template",
      "alwaysOutputData": true,
      "credentials": {
        "googleApi": {
          "id": "XlFwzHsP62pz7O9I",
          "name": "Google Service Account account"
        }
      }
    },
    {
      "parameters": {
        "conditions": {
          "options": {
            "caseSensitive": true,
            "leftValue": "",
            "typeValidation": "strict",
            "version": 2
          },
          "conditions": [
            {
              "id": "edc8d4a4-2f27-4d70-869e-78a473e5b1b4",
              "leftValue": "={{ $json.isNotEmpty() }}",
              "rightValue": "",
              "operator": {
                "type": "boolean",
                "operation": "true",
                "singleValue": true
              }
            }
          ],
          "combinator": "and"
        },
        "options": {}
      },
      "type": "n8n-nodes-base.if",
      "typeVersion": 2.2,
      "position": [
        1240,
        100
      ],
      "id": "1bf58906-2c8f-46ba-9fcb-bf7e04705549",
      "name": "If"
    },
    {
      "parameters": {
        "authentication": "serviceAccount",
        "operation": "download",
        "fileId": {
          "__rl": true,
          "value": "={{ $json.id }}",
          "mode": "id"
        },
        "options": {
          "binaryPropertyName": "pathwayBinary"
        }
      },
      "type": "n8n-nodes-base.googleDrive",
      "typeVersion": 3,
      "position": [
        1480,
        -80
      ],
      "id": "3620e34d-d7fa-4945-a55c-dde1ded4e431",
      "name": "Download pathway",
      "credentials": {
        "googleApi": {
          "id": "XlFwzHsP62pz7O9I",
          "name": "Google Service Account account"
        }
      }
    },
    {
      "parameters": {
        "errorMessage": "=Pathway could not be found by URL: \"{{ $('On form submission').first().json['Pathway URL'] }}\""
      },
      "type": "n8n-nodes-base.stopAndError",
      "typeVersion": 1,
      "position": [
        1480,
        220
      ],
      "id": "31e8eb94-5d24-401c-b008-1ed85f4901a7",
      "name": "Stop and Error"
    },
    {
      "parameters": {
        "operation": "fromJson",
        "binaryPropertyName": "pathwayBinary",
        "destinationKey": "pathway",
        "options": {}
      },
      "type": "n8n-nodes-base.extractFromFile",
      "typeVersion": 1,
      "position": [
        1740,
        -80
      ],
      "id": "181bf9dc-b4c8-4090-8ef7-1b7968f94b69",
      "name": "Extract Pathway from File"
    },
    {
      "parameters": {
        "content": "## Resolving Pathway",
        "height": 540,
        "width": 980
      },
      "type": "n8n-nodes-base.stickyNote",
      "typeVersion": 1,
      "position": [
        960,
        -140
      ],
      "id": "1c003290-437f-460d-afe7-91ae85dc84f8",
      "name": "Sticky Note1"
    },
    {
      "parameters": {
        "content": "## Triggers",
        "height": 480,
        "width": 500,
        "color": 4
      },
      "type": "n8n-nodes-base.stickyNote",
      "typeVersion": 1,
      "position": [
        -380,
        -40
      ],
      "id": "b7f5cc75-65e5-4682-92cf-a50173b72077",
      "name": "Sticky Note2"
    },
    {
      "parameters": {
        "jsCode": "const treatments = $input.first().json.pathway[0].treatments;\nconst searchedInterventionName = $('Input data').first().json.inverventionName;\n\nreturn treatments.filter(x => x.name === searchedInterventionName);"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        2560,
        -80
      ],
      "id": "a862f811-0eff-40bc-ac14-6d505ab67517",
      "name": "Match intervention by searched name"
    },
    {
      "parameters": {
        "content": "## Filter intervention list",
        "height": 640,
        "width": 1120
      },
      "type": "n8n-nodes-base.stickyNote",
      "typeVersion": 1,
      "position": [
        2080,
        -160
      ],
      "id": "042a8cd6-c435-46c2-9c93-371804e98a5d",
      "name": "Sticky Note3"
    },
    {
      "parameters": {
        "conditions": {
          "options": {
            "caseSensitive": true,
            "leftValue": "",
            "typeValidation": "strict",
            "version": 2
          },
          "conditions": [
            {
              "id": "9b7b0663-6573-4e23-9f30-143b24619304",
              "leftValue": "={{ $json.name }}",
              "rightValue": "",
              "operator": {
                "type": "string",
                "operation": "notEmpty",
                "singleValue": true
              }
            }
          ],
          "combinator": "and"
        },
        "options": {}
      },
      "type": "n8n-nodes-base.if",
      "typeVersion": 2.2,
      "position": [
        2800,
        -80
      ],
      "id": "db785091-ff81-4178-b26c-00cc71de0e39",
      "name": "Check filtered result"
    },
    {
      "parameters": {
        "errorMessage": "=Intervention item is not matched by name: {{ $('On form submission').first().json['Intervention name'] }}"
      },
      "type": "n8n-nodes-base.stopAndError",
      "typeVersion": 1,
      "position": [
        3040,
        20
      ],
      "id": "46f82cba-fa69-4c79-b092-7afb37787732",
      "name": "Stop and Error2"
    },
    {
      "parameters": {
        "rules": {
          "values": [
            {
              "conditions": {
                "options": {
                  "caseSensitive": true,
                  "leftValue": "",
                  "typeValidation": "strict",
                  "version": 2
                },
                "conditions": [
                  {
                    "leftValue": "={{ $('Input data').first().json.inverventionName }}",
                    "rightValue": "",
                    "operator": {
                      "type": "string",
                      "operation": "notEmpty",
                      "singleValue": true
                    }
                  }
                ],
                "combinator": "and"
              },
              "renameOutput": true,
              "outputKey": "Search by intervention name"
            },
            {
              "conditions": {
                "options": {
                  "caseSensitive": true,
                  "leftValue": "",
                  "typeValidation": "strict",
                  "version": 2
                },
                "conditions": [
                  {
                    "id": "0342270e-7267-4dab-a132-81a73af16fac",
                    "leftValue": "={{ $('Input data').first().json.searchType }}",
                    "rightValue": "",
                    "operator": {
                      "type": "string",
                      "operation": "empty",
                      "singleValue": true
                    }
                  }
                ],
                "combinator": "and"
              },
              "renameOutput": true,
              "outputKey": "Default"
            },
            {
              "conditions": {
                "options": {
                  "caseSensitive": true,
                  "leftValue": "",
                  "typeValidation": "strict",
                  "version": 2
                },
                "conditions": [
                  {
                    "id": "5be85ca7-d8e8-4d4f-8f38-1481de8d949a",
                    "leftValue": "={{ $('Input data').first().json.searchType }}",
                    "rightValue": "Full search",
                    "operator": {
                      "type": "string",
                      "operation": "equals",
                      "name": "filter.operator.equals"
                    }
                  }
                ],
                "combinator": "and"
              },
              "renameOutput": true,
              "outputKey": "Full search"
            },
            {
              "conditions": {
                "options": {
                  "caseSensitive": true,
                  "leftValue": "",
                  "typeValidation": "strict",
                  "version": 2
                },
                "conditions": [
                  {
                    "id": "4b021816-9d55-4e89-aad0-769592cbe19f",
                    "leftValue": "={{ $('Input data').first().json.searchType }}",
                    "rightValue": "RAG search",
                    "operator": {
                      "type": "string",
                      "operation": "equals",
                      "name": "filter.operator.equals"
                    }
                  }
                ],
                "combinator": "and"
              },
              "renameOutput": true,
              "outputKey": "RAG based search"
            }
          ]
        },
        "options": {}
      },
      "type": "n8n-nodes-base.switch",
      "typeVersion": 3.2,
      "position": [
        2160,
        120
      ],
      "id": "8268483c-9a26-4d97-bbde-6cdf0e3c2566",
      "name": "Switch filter interventions"
    },
    {
      "parameters": {
        "jsCode": "return $input.all().map(x => {\n  return {\n    originItem: x.json,\n    // will be populated later\n    matchResult: null,\n    matchedDosage: null,\n    validationResults: [],\n    history: []\n  };\n});"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        5200,
        -100
      ],
      "id": "83a8f232-9092-44ca-8939-c383d4d952ce",
      "name": "Map results to final object"
    },
    {
      "parameters": {
        "jsCode": "function prompt(medicationData) {\n  return `\nYou are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both \\`inclusionTrigger\\` and \\`exclusionTrigger\\` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as \\`objective\\`, \\`benefit\\`, \\`supportingActivities\\` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the \\`dosages\\` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if \\`options\\` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n${JSON.stringify(medicationData)}\n`.trim();\n}\n\nconst anamnesis = $('Generate patient anamnesis').first().json.anamnesis;\nconst userPrompt = `\n### **Patient data:**\n\n${anamnesis}\n`.trim();\n\nreturn $input.all().map(x => {\n  return {\n    ...x.json,\n    history: [\n      {\n        role: 'system',\n        content: prompt(x)\n      },\n      {\n        role: 'user',\n        content: userPrompt\n      }\n    ]\n  };\n});"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        5500,
        -100
      ],
      "id": "e0098a34-2e5f-4f9e-b924-c2777f9d1d3b",
      "name": "Prepare initial prompts"
    },
    {
      "parameters": {
        "jsCode": "return [\n  {\n    interventionItems: $input.all().map(x => x.json),\n    executionTime: '',\n    generatedAt: $now.toISO()\n  }\n];"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        8460,
        -140
      ],
      "id": "4898644e-54ad-45ae-8c2e-9efbb4d82d3a",
      "name": "Format response"
    },
    {
      "parameters": {
        "authentication": "serviceAccount",
        "inputDataFieldName": "file",
        "name": "={{ $input.item.binary.file.fileName }}",
        "driveId": {
          "__rl": true,
          "mode": "list",
          "value": "My Drive"
        },
        "folderId": {
          "__rl": true,
          "value": "1h5xcHGWF-lwHMp5x_OtPKqcyU1zw5ejg",
          "mode": "list",
          "cachedResultName": "responses",
          "cachedResultUrl": "https://drive.google.com/drive/folders/1h5xcHGWF-lwHMp5x_OtPKqcyU1zw5ejg"
        },
        "options": {}
      },
      "type": "n8n-nodes-base.googleDrive",
      "typeVersion": 3,
      "position": [
        9660,
        -60
      ],
      "id": "1d3314af-a61d-4d48-b509-8a7d3fd264bf",
      "name": "Google Drive",
      "credentials": {
        "googleApi": {
          "id": "XlFwzHsP62pz7O9I",
          "name": "Google Service Account account"
        }
      }
    },
    {
      "parameters": {
        "jsCode": "function printMatches(matchedItems) {\n  let markdown = '';\n  \n  for (let index = 0; index < matchedItems.length; index++) {\n    const item = matchedItems[index];\n    const intervention = item.originItem;\n    const matchResult = item.matchResult;\n    const matchedDosage = item.matchedDosage;\n    const reason = matchResult.recommendationReason ? matchResult.recommendationReason : matchResult.notRecommendationReason;\n  \n    markdown += `**${index + 1}. ${intervention.name}**\\n`;\n\n    if (reason) {\n      markdown += `  - Reason: ${reason}\\n`;\n    }\n\n    const retries = item.validationResults.length - 1;\n\n    markdown += `  - Retries: ${retries}\\n`;\n\n    if (!matchResult.isRecommended) {\n      markdown += '\\n';\n      continue;\n    }\n  \n    if (matchResult.option) {\n      markdown += `  - Option: ${matchResult.option}\\n`;\n    }\n  \n    if (matchedDosage) {\n      markdown += `  - Dosage: ${matchedDosage.dosage}\\n`;\n      markdown += `  - Dosage Frequency: ${matchedDosage.frequency}\\n`;\n  \n      if (matchedDosage.option) {\n        markdown += `  - Dosage option: ${matchedDosage.option}\\n`;\n      }\n    }\n    else {\n      markdown += `  - Dosage: not matched\\n`;\n      markdown += `  - Not Matched Dosage from: ${matchResult.dosage.dosage}\\n`\n    }\n  \n    if (matchResult.recommendationReason) {\n      markdown += `  - Dosage recommendation reason: ${matchResult.recommendationReason}\\n`\n    }\n  \n    if (intervention.dossingInstructions) {\n      markdown += `  - Dossign instructions: ${intervention.dossingInstructions}\\n`;\n    }\n  \n    markdown += '\\n';\n  }\n\n  return markdown;\n}\n\nlet markdown = ``;\nlet data = $input.first().json;\n\nmarkdown += '# Health Plan\\n\\n';\nmarkdown += `Generated at: ${DateTime.fromISO(data.generatedAt).toLocaleString(DateTime.DATETIME_SHORT_WITH_SECONDS)}\\n`;\nmarkdown += `Execution time: ${data.executionTime}\\n\\n`;\n\nmarkdown += '## Matched items\\n\\n';\n\nconst matchedItems = data.interventionItems.filter(x => x.matchResult.isRecommended);\n\nif (matchedItems.length > 0) {\n  markdown += printMatches(matchedItems);\n} else {\n  markdown += '**No matches**\\n';\n}\n\nmarkdown += '\\n';\n\nmarkdown += '## NOT Matched items\\n\\n';\n\nconst notMatchedItems = data.interventionItems.filter(x => !x.matchResult.isRecommended);\n\nif (notMatchedItems.length > 0) {\n  markdown += printMatches(notMatchedItems);\n} else {\n  markdown += '**No matches**\\n';\n}\n\nreturn [\n  {\n    markdown\n  }\n];"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        8880,
        100
      ],
      "id": "c412be45-c0a7-4c80-8490-975479ca70cd",
      "name": "Format health plan markdown"
    },
    {
      "parameters": {},
      "type": "n8n-nodes-base.merge",
      "typeVersion": 3,
      "position": [
        9340,
        -60
      ],
      "id": "4ad3ad84-7ca8-4f10-af91-08fe14a6b540",
      "name": "Merge"
    },
    {
      "parameters": {
        "content": "## Intervention matching",
        "height": 740,
        "width": 2480
      },
      "type": "n8n-nodes-base.stickyNote",
      "typeVersion": 1,
      "position": [
        5060,
        -280
      ],
      "id": "1b569202-fd01-4825-a596-9f65ad563006",
      "name": "Sticky Note4"
    },
    {
      "parameters": {
        "content": "## Result",
        "height": 480,
        "width": 880,
        "color": 4
      },
      "type": "n8n-nodes-base.stickyNote",
      "typeVersion": 1,
      "position": [
        7720,
        -280
      ],
      "id": "b1189e76-0c5d-484c-9253-15ee8e7ffb57",
      "name": "Sticky Note6"
    },
    {
      "parameters": {
        "content": "## Saving result to google drive",
        "height": 640,
        "width": 1060
      },
      "type": "n8n-nodes-base.stickyNote",
      "typeVersion": 1,
      "position": [
        8760,
        -280
      ],
      "id": "ccafa68e-2035-4d3d-af7b-c627f8ed85f9",
      "name": "Sticky Note7"
    },
    {
      "parameters": {
        "jsCode": "return $('Format response').all().map(x => {\n  const markdown = $('Format health plan markdown').first().json.markdown;\n  const files = $input.all().map(x => x.json);\n  const markdownFileUrl = files.find(x => x.fileExtension === 'md').webViewLink;\n\n  return {\n    ...x.json,\n    markdown,\n    markdownFileUrl\n  }\n});"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        10040,
        -60
      ],
      "id": "7c07c2b4-8da5-4fa5-ada6-24b36492952b",
      "name": "Output"
    },
    {
      "parameters": {
        "jsCode": "return $input.all();"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        280,
        100
      ],
      "id": "ed3a22cf-9ea4-4785-a1c6-6837211cda84",
      "name": "Input data"
    },
    {
      "parameters": {
        "jsCode": "return $input.first().json.pathway.treatments;"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        2560,
        260
      ],
      "id": "4c607f72-0f20-479f-b3df-191c16d22da8",
      "name": "Get all interventions"
    },
    {
      "parameters": {},
      "type": "n8n-nodes-base.executeWorkflowTrigger",
      "typeVersion": 1,
      "position": [
        -300,
        60
      ],
      "id": "0aa8dfa7-f590-49e5-94b7-b0e100cedcc5",
      "name": "Execute Workflow Trigger",
      "disabled": true
    },
    {
      "parameters": {
        "operation": "toJson",
        "binaryPropertyName": "file",
        "options": {
          "format": true,
          "encoding": "utf8",
          "fileName": "=health-plan-{{ $json.generatedAt }}.json"
        }
      },
      "type": "n8n-nodes-base.convertToFile",
      "typeVersion": 1.1,
      "position": [
        8880,
        -140
      ],
      "id": "f4883569-680d-4645-8427-7fd874f2669d",
      "name": "Convert to JSON File"
    },
    {
      "parameters": {
        "operation": "toText",
        "sourceProperty": "markdown",
        "binaryPropertyName": "file",
        "options": {
          "encoding": "utf8",
          "fileName": "=health-plan-{{ $('Format response').first().json.generatedAt }}.md"
        }
      },
      "type": "n8n-nodes-base.convertToFile",
      "typeVersion": 1.1,
      "position": [
        9100,
        100
      ],
      "id": "da3c3769-8dd5-4414-a4c6-99c542e27de0",
      "name": "Convert to MD file"
    },
    {
      "parameters": {
        "jsCode": "return [\n  {\n    // \"pathwayUrl\": \"https://fhir.aera.health/fhir/R4/PlanDefinition/507faf19-f6bf-4257-877a-db170acde737\",\n    \"pathwayUrl\": \"https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41\",\n    \"inverventionName\": \"\",\n    \"searchType\": \"RAG search\",\n    \"bloodResultsData\":\n    {\n        \"date\": \"05/06/2023\",\n        \"results\":\n        [\n            {\n                \"test\": \"HAEMOGLOBIN\",\n                \"range\": \"130 - 170\",\n                \"unit\": \"g/L\",\n                \"value\": 147\n            },\n            {\n                \"test\": \"HCT\",\n                \"range\": \"0.37 - 0.50\",\n                \"value\": 0.448\n            },\n            {\n                \"test\": \"RED CELL COUNT\",\n                \"range\": \"4.40 - 5.80\",\n                \"unit\": \"x10^12/L\",\n                \"value\": 4.78\n            },\n            {\n                \"test\": \"MCV\",\n                \"range\": \"80 - 99\",\n                \"unit\": \"fL\",\n                \"value\": 93.7\n            },\n            {\n                \"test\": \"MCH\",\n                \"range\": \"27.0 - 33.5\",\n                \"unit\": \"pg\",\n                \"value\": 30.8\n            },\n            {\n                \"test\": \"MCHC\",\n                \"range\": \"300 - 350\",\n                \"unit\": \"g/L\",\n                \"value\": 328\n            },\n            {\n                \"test\": \"RDW\",\n                \"range\": \"11.5 - 15.0\",\n                \"value\": 12.0\n            },\n            {\n                \"test\": \"PLATELET COUNT\",\n                \"range\": \"150 - 400\",\n                \"unit\": \"x10^9/L\",\n                \"value\": 174\n            },\n            {\n                \"test\": \"MPV\",\n                \"range\": \"7 - 13\",\n                \"unit\": \"fL\",\n                \"value\": 10.9\n            },\n            {\n                \"test\": \"WHITE CELL COUNT\",\n                \"range\": \"3.0 - 10.0\",\n                \"unit\": \"x10^9/L\",\n                \"value\": 5.95\n            },\n            {\n                \"test\": \"Neutrophils\",\n                \"range\": \"2.0 - 7.5\",\n                \"unit\": \"x10^9/L\",\n                \"value\": 3.43,\n                \"percentage\": 57.6\n            },\n            {\n                \"test\": \"Lymphocytes\",\n                \"range\": \"1.2 - 3.65\",\n                \"unit\": \"x10^9/L\",\n                \"value\": 2.02,\n                \"percentage\": 33.9\n            },\n            {\n                \"test\": \"Monocytes\",\n                \"range\": \"0.2 - 1.0\",\n                \"unit\": \"x10^9/L\",\n                \"value\": 0.44,\n                \"percentage\": 7.4\n            },\n            {\n                \"test\": \"Eosinophils\",\n                \"range\": \"0.0 - 0.4\",\n                \"unit\": \"x10^9/L\",\n                \"value\": 0.05,\n                \"percentage\": 0.8\n            },\n            {\n                \"test\": \"Basophils\",\n                \"range\": \"0.0 - 0.1\",\n                \"unit\": \"x10^9/L\",\n                \"value\": 0.02,\n                \"percentage\": 0.3\n            },\n            {\n                \"test\": \"ALBUMIN\",\n                \"range\": \"34 - 50\",\n                \"unit\": \"g/L\",\n                \"value\": 46\n            },\n            {\n                \"test\": \"Prostate Specific Ag (Total)\",\n                \"range\": \"0.00 - 2.99\",\n                \"unit\": \"ug/L\",\n                \"value\": 0.29\n            },\n            {\n                \"test\": \"FOLLICLE STIM. HORMONE\",\n                \"range\": \"1.5 - 12.4\",\n                \"unit\": \"IU/L\",\n                \"value\": 3.3\n            },\n            {\n                \"test\": \"LUTEINISING HORMONE\",\n                \"range\": \"1.7 - 8.6\",\n                \"unit\": \"IU/L\",\n                \"value\": 2.5\n            },\n            {\n                \"test\": \"PROGESTERONE\",\n                \"range\": \"0.2 - 0.5\",\n                \"unit\": \"nmol/L\",\n                \"value\": 0.5\n            },\n            {\n                \"test\": \"TESTOSTERONE\",\n                \"range\": \"7.6 - 31.4\",\n                \"unit\": \"nmol/L\",\n                \"value\": 20.8\n            },\n            {\n                \"test\": \"SEX HORMONE BINDING GLOB\",\n                \"range\": \"19 - 83\",\n                \"unit\": \"nmol/L\",\n                \"value\": 70\n            },\n            {\n                \"test\": \"PROLACTIN\",\n                \"range\": \"86 - 324\",\n                \"unit\": \"mIU/L\",\n                \"value\": 113\n            },\n            {\n                \"test\": \"17-Beta OESTRADIOL\",\n                \"range\": \"< 192\",\n                \"unit\": \"pmol/L\",\n                \"value\": 81\n            },\n            {\n                \"test\": \"D.H.E.A. Sulphate\",\n                \"range\": \"0.44 - 13.4\",\n                \"unit\": \"umol/L\",\n                \"value\": 5.7\n            },\n            {\n                \"test\": \"Free Testosterone\",\n                \"range\": \"5.0 - 21.0\",\n                \"unit\": \"pg/ml\",\n                \"value\": 8.2\n            },\n            {\n                \"test\": \"Dihydrotestosterone\",\n                \"range\": \"0.33 - 3.01\",\n                \"unit\": \"nmol/L\",\n                \"value\": 1.61\n            }\n        ]\n    },\n    \"questionnaireResultsData\": null,\n    \"patientProfile\": \"# Patient profile\\r\\n\\r\\n- Age: 58\\r\\n- DOB: 1966\\r\\n- Gender: male\\r\\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\\r\\n\\r\\n---\\r\\n\\r\\n# Social  \\r\\n\\r\\n**Date: 12\\/02\\/2020**  \\r\\n- otherwise well  \\r\\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \\r\\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \\r\\n\\r\\n**Date: 10\\/09\\/2018**  \\r\\n- Ex-Cigar Smoker  \\r\\n\\r\\n**Date: 11\\/05\\/2017**  \\r\\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \\r\\n- Non-smoker  \\r\\n- 3-4 times a week  \\r\\n- 1-2 hours per week  \\r\\n- company director  \\r\\n- Smoked for 28 years, 20 a day, 28 pack day history  \\r\\n- Married  \\r\\n- Light drinker - 1-2u\\/day  \\r\\n\\r\\n---\\r\\n\\r\\n# Medical history  \\r\\n\\r\\n**Date: 07\\/06\\/2023**  \\r\\n- Discussed sharing records with NHS practice  \\r\\n\\r\\n**Date: 25\\/03\\/2023**  \\r\\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \\r\\n\\r\\n**Date: 01\\/11\\/2021**  \\r\\n- Systolic BP: 110  \\r\\n- Diastolic BP: 72  \\r\\n\\r\\n**Date: 10\\/02\\/2021**  \\r\\n- Weight: 90.2  \\r\\n- BMI: 28.47  \\r\\n\\r\\n**Date: 05\\/12\\/2020**  \\r\\n- Blood Pressure: 121.78  \\r\\n\\r\\n**Date: 12\\/02\\/2020**  \\r\\n- Height: 178  \\r\\n\\r\\n**Date: 10\\/09\\/2018**  \\r\\n- Pulse: 77  \\r\\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \\r\\n\\r\\n**Date: 27\\/10\\/2017**  \\r\\n- Blood Oxygen: 97  \\r\\n- lungs clear, good a\\/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \\r\\n\\r\\n---\\r\\n\\r\\n# Medication  \\r\\n\\r\\n**Date: 12\\/02\\/2020**  \\r\\n- Omega 3 and Krill oil\\r\\n\\r\\n**Date: 10\\/09\\/2018**  \\r\\n- aspirin 75mg  \\r\\n\\r\\n**Date: 05\\/01\\/2017**  \\r\\n- nil  \\r\\n\\r\\n---\\r\\n\\r\\n# Family history  \\r\\n\\r\\n**Date: 10\\/09\\/2018**  \\r\\n- Younger brother recently Dx AF at 47yo  \\r\\n\\r\\n**Date: 11\\/05\\/2017**  \\r\\n- Unsure of who father is  \\r\\n- Mum: 75 years old - OA  \\r\\n- Has two brothers  \\r\\n- Brothers have no medical problems  \\r\\n- Mum has AF  \\r\\n- Brother-in-law: Prostate cancer  \\r\\n\\r\\n---\\r\\n\\r\\n# Allergy  \\r\\n\\r\\n**Date: 05\\/01\\/2017**  \\r\\n- NKDA\\r\\n\"\n  }\n];"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        -60,
        260
      ],
      "id": "f5deb54c-6a3e-4137-a4fb-ee8d10b2178a",
      "name": "Mock data"
    },
    {
      "parameters": {},
      "type": "n8n-nodes-base.manualTrigger",
      "typeVersion": 1,
      "position": [
        -300,
        260
      ],
      "id": "e1c22b88-656e-4bdc-be1f-89296727b5af",
      "name": "Debug trigger",
      "disabled": true
    },
    {
      "parameters": {
        "promptType": "define",
        "text": "={{ $json.history[1].content }}",
        "messages": {
          "messageValues": [
            {
              "message": "={{ $json.history[0].content }}"
            }
          ]
        }
      },
      "type": "@n8n/n8n-nodes-langchain.chainLlm",
      "typeVersion": 1.5,
      "position": [
        2820,
        740
      ],
      "id": "9cd6418d-4151-406e-98bf-8d9d1089304b",
      "name": "Generate RAG search queries",
      "retryOnFail": true,
      "waitBetweenTries": 5000,
      "maxTries": 5
    },
    {
      "parameters": {
        "model": "gpt-4o",
        "options": {}
      },
      "type": "@n8n/n8n-nodes-langchain.lmChatOpenAi",
      "typeVersion": 1,
      "position": [
        2900,
        940
      ],
      "id": "12d051b8-6e74-4894-a13e-0fa811b18a0d",
      "name": "OpenAI Chat Model1",
      "credentials": {
        "openAiApi": {
          "id": "efHlwehLp2xTvVDY",
          "name": "OpenAi account"
        }
      }
    },
    {
      "parameters": {
        "jsCode": "const systemPrompt = `\nYou are an assistant tasked with generating precise **RAG search queries** to filter medications and treatments for a personalized Patient Health Plan.  \n\n### **Task Instructions:**  \n\n1. **Identify Key Moments**:  \n   Analyze the patient’s data to extract \"key moments,\" including:  \n   - Symptoms (e.g., \"Regularly gets tired\").  \n   - Lab results (e.g., \"Low B12\", \"Low Vitamin D\").  \n   - Hormone levels (e.g., \"Free Testosterone - 0.2 mol/L\").  \n   - Lifestyle factors or medical history (e.g., \"Busy life\", \"History of impotence\").  \n\n2. **Generate Specific Queries**:  \n   For each key moment, write a concise and actionable RAG search query targeting:  \n   - Relevant treatments or interventions.  \n   - Diagnostic recommendations.\n\n3. **Provide Reasoning**:  \n   For each query, include a brief explanation that outlines:  \n   - The relevance of the query to the patient’s condition.  \n   - Any contextual alignment with inclusion or exclusion triggers.  \n\n4. **Ensure Alignment**:  \n  Queries should align with inclusion and exclusion triggers for treatments and focus on personalized, effective options.  \n\n### **Examples:**  \n1. **Key Moment**: \"DHEA Sulphate - 2.5 umol/L\"  \n   **Query**: \"Find all medications with inclusion criteria for patients where DHEA sulphate levels are 6 umol/L or lower.\"  \n   **Reason**: \"DHEA sulphate is significantly low in this patient, and supplementation may improve hormone balance and energy levels.\"  \n\n2. **Key Moment**: \"Low Vitamin D\"  \n   **Query**: \"Retrieve all medications where the inclusion trigger specifies low Vitamin D levels. Include options with descriptions or criteria matching serum 25-hydroxyvitamin D levels below 50 nmol/L or related deficiencies.\"  \n   **Reason**: \"The patient has a documented deficiency, and targeted supplementation may improve bone health and fatigue.\"  \n\n3. **Key Moment**: \"History of impotence for 15 years\"  \n   **Query**: \"Retrieve testosterone replacement options for men with low free testosterone. Include therapies compatible with a history of impotence and consider implications for new relationships.\"  \n   **Reason**: \"Testosterone deficiency may contribute to erectile dysfunction and decreased libido, which are affecting the patient’s quality of life.\"  \n`.trim();\n\nconst userPrompt = `\nUser data:\n\n${$('Generate patient anamnesis').first().json.anamnesis}\n`.trim();\n\nreturn [\n  {\n    history: [\n      {\n        role: 'system',\n        content: systemPrompt\n      },\n      {\n        role: 'assistant',\n        content: userPrompt\n      }\n    ]\n  }\n];"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        2480,
        740
      ],
      "id": "51a0d467-e706-400c-8b67-805528f171a0",
      "name": "Prepare prompt for RAG queries generation"
    },
    {
      "parameters": {
        "model": "gpt-4o",
        "options": {
          "responseFormat": "json_object"
        }
      },
      "type": "@n8n/n8n-nodes-langchain.lmChatOpenAi",
      "typeVersion": 1,
      "position": [
        3220,
        960
      ],
      "id": "ea0941ac-2eb9-4b42-b001-2333d3b7452f",
      "name": "OpenAI Chat Model2",
      "credentials": {
        "openAiApi": {
          "id": "efHlwehLp2xTvVDY",
          "name": "OpenAi account"
        }
      }
    },
    {
      "parameters": {
        "jsonSchemaExample": "{\n\t\"queries\": [\n      {\n        \"query\": \"Query text\",\n        \"reason\": \"Reason for generated query\"\n      }\n    ]\n}"
      },
      "type": "@n8n/n8n-nodes-langchain.outputParserStructured",
      "typeVersion": 1.2,
      "position": [
        3380,
        960
      ],
      "id": "7e156e1c-1749-4928-8d8c-6e9b9307def0",
      "name": "Structured Output Parser1"
    },
    {
      "parameters": {
        "promptType": "define",
        "text": "=# Message History\n\n**System:**\n{{ $('Prepare prompt for RAG queries generation').item.json.history[0].content }}\n\n**User:**\n{{ $('Prepare prompt for RAG queries generation').item.json.history[1].content }}\n\n**Assistant:**\n{{ $json.text }}",
        "hasOutputParser": true,
        "messages": {
          "messageValues": [
            {
              "message": "Format your response in JSON format."
            }
          ]
        }
      },
      "type": "@n8n/n8n-nodes-langchain.chainLlm",
      "typeVersion": 1.5,
      "position": [
        3180,
        740
      ],
      "id": "dc462edc-25c1-421c-ab5c-9a1c92144778",
      "name": "Format as JSON",
      "retryOnFail": true,
      "waitBetweenTries": 5000,
      "maxTries": 5
    },
    {
      "parameters": {
        "fieldToSplitOut": "output.queries",
        "options": {}
      },
      "type": "n8n-nodes-base.splitOut",
      "typeVersion": 1,
      "position": [
        3580,
        740
      ],
      "id": "d1059cf7-9e57-46d7-a822-0476826e0033",
      "name": "Split Out"
    },
    {
      "parameters": {
        "jsCode": "return [\n  {\n    kernelMemory: {\n      baseUrl: 'http://kernel_service:9001',\n      collectionIndex: 'interventionsv1'\n    },\n    ragSearchInterventionsLimit: 20\n  }\n];"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        520,
        100
      ],
      "id": "2d2cd583-5161-4c21-8fd1-79e06a052863",
      "name": "Config"
    },
    {
      "parameters": {
        "method": "POST",
        "url": "={{ $('Config').first().json.kernelMemory.baseUrl }}/search",
        "sendBody": true,
        "specifyBody": "json",
        "jsonBody": "={\n  \"index\": \"{{ $('Config').first().json.kernelMemory.collectionIndex }}\",\n  \"query\": \"{{ $json.query }}\",\n  \"filters\": [\n    {\n      \"pathwayUrl\": [\n        \"{{ $('Input data').first().json.pathwayUrl }}\"\n      ]\n    }\n  ],\n  \"limit\": 3,\n  \"args\": {\n  }\n}",
        "options": {}
      },
      "type": "n8n-nodes-base.httpRequest",
      "typeVersion": 4.2,
      "position": [
        3840,
        740
      ],
      "id": "6181a3f9-3c40-48ed-8cff-7144efcc9a81",
      "name": "Search Intervention Items"
    },
    {
      "parameters": {
        "conditions": {
          "options": {
            "caseSensitive": true,
            "leftValue": "",
            "typeValidation": "strict",
            "version": 2
          },
          "conditions": [
            {
              "id": "43beaefd-26bf-48fd-a304-6b222c0c8e3c",
              "leftValue": "={{ $json.noResult }}",
              "rightValue": "",
              "operator": {
                "type": "boolean",
                "operation": "true",
                "singleValue": true
              }
            }
          ],
          "combinator": "and"
        },
        "options": {}
      },
      "type": "n8n-nodes-base.if",
      "typeVersion": 2.2,
      "position": [
        4060,
        740
      ],
      "id": "95c546a1-a5d4-407c-b441-7dc7164843c3",
      "name": "If no results"
    },
    {
      "parameters": {},
      "type": "n8n-nodes-base.noOp",
      "typeVersion": 1,
      "position": [
        4400,
        660
      ],
      "id": "272338c9-ca47-4b15-9a7a-c18ccf2c4595",
      "name": "No Operation, do nothing"
    },
    {
      "parameters": {
        "jsCode": "return $input.all().map(x => x.json.intervention);"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        4740,
        860
      ],
      "id": "8bdcb14d-6d0f-471b-9cfb-91a56019f6f4",
      "name": "Map to interventions"
    },
    {
      "parameters": {
        "content": "## RAG based interventions filtering",
        "height": 560,
        "width": 2600
      },
      "type": "n8n-nodes-base.stickyNote",
      "typeVersion": 1,
      "position": [
        2360,
        580
      ],
      "id": "733dcadb-cd67-4643-817b-41bdd76f49a2",
      "name": "Sticky Note"
    },
    {
      "parameters": {
        "jsCode": "function reverseFlat(array, maxItems) {\n    const result = [];\n    const maxRowLength = Math.max(...array.map(x => x.results.length));\n    \n    for (let i = 0; i < maxRowLength; ++i) {\n        for (let j = 0; j < array.length; ++j) {\n            if (i >= array[j].results.length)\n                continue;\n                \n            const item = array[j].results[i];\n            \n            if (result.find(x => x.item.documentId == item.documentId))\n                continue;\n            \n            result.push({\n              query: array[j].query,\n              item\n            });\n                \n            if (result.length == maxItems)\n                return result;\n        }\n    }\n    \n    return result;\n}\n\n// ================================================================= //\n\n// all items sorted by first match result relevance (desc)\nconst queriesResults = $input\n  .all()\n  .map(x => x.json)\n  .sort((a, b) => {\n    const getRev = (x) => x.results[0].partitions[0].relevance;\n    return getRev(b) - getRev(a);\n  })\n  ;\n\nconsole.log(\"1\", items);\n\nconst itemsLimit = $('Config').first().json.ragSearchInterventionsLimit;\n\nconst resultItems = reverseFlat(queriesResults, items);\n\nconst pathway = $('Extract Pathway from File').first().json.pathway[0];\n\nreturn resultItems.map(x => {\n  const intervention = pathway.treatments.find(t => t.name.toLowerCase() === x.item.partitions[0].tags['name'][0].toLowerCase());\n\n  return {\n    ...x,\n    intervention\n  }\n}).filter(x => !!x.intervention);"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        4400,
        860
      ],
      "id": "dd9ae693-88ad-4fec-b336-3453b7e0d45f",
      "name": "Prefilter and limit interventions by search results"
    },
    {
      "parameters": {
        "conditions": {
          "options": {
            "caseSensitive": true,
            "leftValue": "",
            "typeValidation": "strict",
            "version": 2
          },
          "conditions": [
            {
              "id": "087d07c4-d8f7-42dc-aaa0-780aaa1a2653",
              "leftValue": "={{ $json.validationResults.last().isValid }}",
              "rightValue": "",
              "operator": {
                "type": "boolean",
                "operation": "true",
                "singleValue": true
              }
            }
          ],
          "combinator": "and"
        },
        "options": {}
      },
      "type": "n8n-nodes-base.if",
      "typeVersion": 2.2,
      "position": [
        7820,
        -140
      ],
      "id": "76b69a21-9f17-4c60-b8ee-3a232b89ab0b",
      "name": "Check if match result is valid (final)"
    },
    {
      "parameters": {
        "jsCode": "return $input.all().map(x => {\n  const item = x.json;\n  const lastValidationResult = item.validationResults[item.validationResults.length - 1];\n  const reasons = lastValidationResult.reasons.map(r => ' - ' + r).join('\\n');\n\n  item.matchResult = {\n    isRecommended: false,\n    recommendationReason: '',\n    notRecommendationReason: `Generated Match Result did not pass validation.\\nReasons:\\n${reasons}`,    \n    option: '',\n    dosage: null\n  };\n  item.matchedDosage = null;\n  \n  return item;\n});"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        8040,
        20
      ],
      "id": "4500310b-ce45-44a8-8648-fd7eb64422a0",
      "name": "Map invalid results as not matched",
      "notesInFlow": true,
      "notes": "In theory never should go here"
    },
    {
      "parameters": {},
      "type": "n8n-nodes-base.merge",
      "typeVersion": 3,
      "position": [
        8260,
        -140
      ],
      "id": "5c9dc788-45ea-4ce5-88b4-9d968fc9d691",
      "name": "Merge final results"
    },
    {
      "parameters": {
        "workflowId": {
          "__rl": true,
          "value": "eFv4ckp62OkUBIuA",
          "mode": "list",
          "cachedResultName": "Match sub-workflow"
        },
        "options": {}
      },
      "type": "n8n-nodes-base.executeWorkflow",
      "typeVersion": 1.1,
      "position": [
        5840,
        -100
      ],
      "id": "fc5cfc68-0f4e-4f39-b54d-940ed28c2049",
      "name": "Match and Validate Try 0"
    },
    {
      "parameters": {
        "jsCode": "return $input.all();"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        6120,
        -100
      ],
      "id": "510dea6a-26ba-499c-ba18-b807ccaaaa32",
      "name": "Results after try 0"
    },
    {
      "parameters": {
        "workflowId": {
          "__rl": true,
          "value": "eFv4ckp62OkUBIuA",
          "mode": "list",
          "cachedResultName": "Match sub-workflow"
        },
        "options": {}
      },
      "type": "n8n-nodes-base.executeWorkflow",
      "typeVersion": 1.1,
      "position": [
        6700,
        180
      ],
      "id": "d945c046-cd19-4fa0-8727-95274127341d",
      "name": "Match and Validate Try  1"
    },
    {
      "parameters": {
        "jsCode": "return $input.all();"
      },
      "type": "n8n-nodes-base.code",
      "typeVersion": 2,
      "position": [
        7000,
        180
      ],
      "id": "dfe2c30c-22f2-48e3-ba8e-8e0dfb6ce2ff",
      "name": "Results after try 1"
    },
    {
      "parameters": {},
      "type": "n8n-nodes-base.merge",
      "typeVersion": 3,
      "position": [
        7360,
        -100
      ],
      "id": "8c0349a7-59b1-441a-8da6-c5380dfa07fa",
      "name": "Merge1"
    },
    {
      "parameters": {
        "conditions": {
          "options": {
            "caseSensitive": true,
            "leftValue": "",
            "typeValidation": "strict",
            "version": 2
          },
          "conditions": [
            {
              "id": "da77b3a8-572e-497d-87b7-3384fa01db87",
              "leftValue": "={{ $json.validationResults.last().isValid }}",
              "rightValue": "",
              "operator": {
                "type": "boolean",
                "operation": "true",
                "singleValue": true
              }
            }
          ],
          "combinator": "and"
        },
        "options": {}
      },
      "type": "n8n-nodes-base.if",
      "typeVersion": 2.2,
      "position": [
        6380,
        -100
      ],
      "id": "7a0591b1-ad35-4dcb-a87d-1881d650bd95",
      "name": "Check if last result is valid 0"
    }
  ],
  "pinData": {
    "Generate RAG search queries": [
      {
        "json": {
          "text": "To generate RAG search queries for the personalized Patient Health Plan, we'll examine the \"key moments\" extracted from the patient data and proceed with specific queries and reasoning.\n\n### Key Moments and Queries\n\n1. **Key Moment**: \"Symptoms of Insomnia and Fatigue\"\n   - **Query**: \"Identify non-pharmacological interventions and medications suitable for managing insomnia and fatigue in a physically active 58-year-old male.\"\n   - **Reason**: The patient experiences insomnia and fatigue, which significantly impact his energy levels. Non-pharmacological interventions like cognitive behavioral therapy for insomnia (CBT-I) or sleep hygiene education may be beneficial alongside any pharmacological options.\n\n2. **Key Moment**: \"Free Testosterone - 8.2 pg/ml\"\n   - **Query**: \"Search for testosterone supplementation options suitable for slightly low free testosterone levels in males with symptoms of low energy and fatigue.\"\n   - **Reason**: Although testosterone levels are within normal range, they are on the lower end, which may contribute to fatigue and decreased energy. Addressing this could enhance vitality and well-being.\n\n3. **Key Moment**: \"Busy lifestyle with regular physical activity\"\n   - **Query**: \"Explore dietary supplements that support energy levels and recovery in physically active individuals with a vegetarian-leaning diet.\"\n   - **Reason**: The patient's busy and active lifestyle alongside a diet skewed towards vegetarianism may require specific supplements like B12 or iron to maintain optimal energy levels.\n\n4. **Key Moment**: \"Omega 3 and Krill Oil usage\"\n   - **Query**: \"Investigate additional or alternative supplements compatible with Omega-3 and krill oil for cardiovascular and cognitive health in older adults.\"\n   - **Reason**: The ongoing use of omega-3 and krill oils indicates a focus on cardiovascular and cognitive wellness. Identifying synergistic supplements could further support health goals.\n\n5. **Key Moment**: \"History of family cardiac issues (AF in brother and mother)\"\n   - **Query**: \"Locate preventive strategies or therapies for individuals at risk of atrial fibrillation, focusing on those with a family history and stress-related lifestyle factors.\"\n   - **Reason**: A familial history of AF and work stress increases the patient's risk. Interventions or lifestyle adjustments could serve as preventive measures. \n\nBy utilizing these tailored queries, we ensure alignment with patient-specific needs, focusing on effective, personalized treatment and lifestyle intervention options."
        }
      }
    ],
    "Format as JSON": [
      {
        "json": {
          "output": {
            "queries": [
              {
                "query": "Identify non-pharmacological interventions and medications suitable for managing insomnia and fatigue in a physically active 58-year-old male.",
                "reason": "The patient experiences insomnia and fatigue, which significantly impact his energy levels. Non-pharmacological interventions like cognitive behavioral therapy for insomnia (CBT-I) or sleep hygiene education may be beneficial alongside any pharmacological options."
              },
              {
                "query": "Search for testosterone supplementation options suitable for slightly low free testosterone levels in males with symptoms of low energy and fatigue.",
                "reason": "Although testosterone levels are within normal range, they are on the lower end, which may contribute to fatigue and decreased energy. Addressing this could enhance vitality and well-being."
              },
              {
                "query": "Explore dietary supplements that support energy levels and recovery in physically active individuals with a vegetarian-leaning diet.",
                "reason": "The patient's busy and active lifestyle alongside a diet skewed towards vegetarianism may require specific supplements like B12 or iron to maintain optimal energy levels."
              },
              {
                "query": "Investigate additional or alternative supplements compatible with Omega-3 and krill oil for cardiovascular and cognitive health in older adults.",
                "reason": "The ongoing use of omega-3 and krill oils indicates a focus on cardiovascular and cognitive wellness. Identifying synergistic supplements could further support health goals."
              },
              {
                "query": "Locate preventive strategies or therapies for individuals at risk of atrial fibrillation, focusing on those with a family history and stress-related lifestyle factors.",
                "reason": "A familial history of AF and work stress increases the patient's risk. Interventions or lifestyle adjustments could serve as preventive measures."
              }
            ]
          }
        }
      }
    ],
    "Search Intervention Items": [
      {
        "json": {
          "query": "Identify non-pharmacological interventions and medications suitable for managing insomnia and fatigue in a physically active 58-year-old male.",
          "noResult": false,
          "results": [
            {
              "link": "interventionsv1/medication_pregnenolone/efeee20ad2cb4811a19ab7149abe4e8c",
              "index": "interventionsv1",
              "documentId": "medication_pregnenolone",
              "fileId": "efeee20ad2cb4811a19ab7149abe4e8c",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_pregnenolone&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Pregnenolone\",\"benefit\":\"Improve sleep & overall hormonal production\",\"objective\":\"Improve sleep and hormone production\",\"exclusionTrigger\":\"Pregnenolone supplementation should be absolutely avoided in individuals with hormone-sensitive cancers (such as breast, ovarian, uterine, or prostate cancer), as well as in those with conditions like endometriosis or uterine fibroids, due to its potential to influence hormone levels. Pregnant or breastfeeding women should also avoid pregnenolone, as its safety in these populations has not been established. People with bipolar disorder or other severe mental health disorders should avoid pregnenolone, as it may exacerbate mood instability or trigger manic episodes. Those with liver or kidney disease are advised against its use, given the body’s reliance on these organs for metabolizing pregnenolone, which could pose a risk.\nFinally, pregnenolone should not be taken by individuals on hormone therapies, such as birth control or hormone replacement therapy, due to potential interactions that could disrupt hormone balance.\",\"inclusionTrigger\":\"Sleep issues, stressfull lifestyle, works a lot, competitive environment\",\"dosages\":[{\"dosage\":\"30mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}],\"description\":\"Pregnenolone is a steroid hormone involved in the synthesis of other steroids, including DHEA and progesterone. It's administered orally and is thought to improve cognitive performance and memory, relieve symptoms of menopause, and enhance mood.\\n\\nIndications:\\n• Cognitive decline\\n• Mood disorders\\n• Hormonal imbalances\\n\\nContraindications:\\n• Hormone-sensitive cancers\\n• Severe liver or kidney disease\\n• History of seizures\\n\\nPotential Side Effects:\\n• Overstimulation and insomnia\\n• Mood swings\\n• Headaches\\n• Irregular heart rhythms\"}",
                  "relevance": 0.3511582,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_pregnenolone"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "efeee20ad2cb4811a19ab7149abe4e8c"
                    ],
                    "__file_part": [
                      "82d0671ffa884bf4ab268c9cae0763cc"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Pregnenolone"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_testosterone/397d01995cee4692ac727831b5c32891",
              "index": "interventionsv1",
              "documentId": "medication_testosterone",
              "fileId": "397d01995cee4692ac727831b5c32891",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_testosterone&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Testosterone\",\"benefit\":\"\",\"objective\":\"Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)\",\"exclusionTrigger\":\"Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions\",\"inclusionTrigger\":\"\",\"dosages\":[{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.45nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"25mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.40nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"40mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.35nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.30nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"60mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.\n25nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"75mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.20nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"90mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.15nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"100mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.10nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"125mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.05nmol/L or lower\",\"exclusionTrigger\":\"\"}],\"description\":\"Testosterone therapy involves the administration of testosterone to treat conditions caused by low levels of testosterone such as hypogonadism. This treatment can be delivered via injections, transdermal patches, or gels, and aims to restore normal levels of testosterone, improving libido, energy, muscle mass, and bone density.\\n\\nIndications:\\n• Male hypogonadism\\n• Delayed puberty in boys\\n• Certain types of breast cancer in women\\n\\nContraindications:\\n• Prostate or breast cancer in men\\n• Severe liver disease\\n• Severe heart failure\\n\\nPotential Side Effects:\\n• Acne, skin irritation\\n• Increased risk of cardiovascular disease\\n• Liver abnormalities\\n• Mood Ideal level: 0,415-0,45 ng/dl\"}",
                  "relevance": 0.34037027,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_testosterone"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "397d01995cee4692ac727831b5c32891"
                    ],
                    "__file_part": [
                      "eb48b9b227be418785603d9a6e0acd23"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Testosterone"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_dhea/786ef7f065114e04bf01f6b88127d8c1",
              "index": "interventionsv1",
              "documentId": "medication_dhea",
              "fileId": "786ef7f065114e04bf01f6b88127d8c1",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_dhea&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"DHEA\",\"benefit\":\"\",\"objective\":\"Bring DHEA sulphate levels to an optimal range (6umol/L)\",\"exclusionTrigger\":\"DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.\n\",\"inclusionTrigger\":\"\",\"dosages\":[{\"dosage\":\"5mg\",\"inclusionTrigger\":\"When DHEA measurements are around 8umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When DHEA measurements are around 7umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"15mg\",\"inclusionTrigger\":\"When DHEA measurements are around 6umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"20mg\",\"inclusionTrigger\":\"When DHEA measurements are around 5umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"30mg\",\"inclusionTrigger\":\"When DHEA measurements are around 4umol/L or lower\",\"exclusionTrigger\":\n\"\"},{\"dosage\":\"35mg\",\"inclusionTrigger\":\"When DHEA measurements are around 3umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"45mg\",\"inclusionTrigger\":\"When DHEA measurements are around 2umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When DHEA measurements are around 1umol/L or lower\",\"exclusionTrigger\":\"\"}],\"description\":\"Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress.\nDHEA is administered orally.\\n\\nIndications:\\n• Adrenal insufficiency\\n• Depression\\n• Systemic lupus erythematosus (SLE)\\n• Aging skin\\n\\nContraindications:\\n• Cancer of the breast, ovaries, or prostate\\n• Severe liver disease\\n• Pregnancy\\n\\nPotential Side Effects:\\n• Oily skin and acne\\n• Hair loss\\n• Stomach upset\\n• High blood pressure\"}",
                  "relevance": 0.321114,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_dhea"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "786ef7f065114e04bf01f6b88127d8c1"
                    ],
                    "__file_part": [
                      "e094cd664f42491cb13ee4cdfafb709e"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "DHEA"
                    ]
                  }
                }
              ]
            }
          ]
        }
      },
      {
        "json": {
          "query": "Search for testosterone supplementation options suitable for slightly low free testosterone levels in males with symptoms of low energy and fatigue.",
          "noResult": false,
          "results": [
            {
              "link": "interventionsv1/medication_testosterone/397d01995cee4692ac727831b5c32891",
              "index": "interventionsv1",
              "documentId": "medication_testosterone",
              "fileId": "397d01995cee4692ac727831b5c32891",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_testosterone&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Testosterone\",\"benefit\":\"\",\"objective\":\"Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)\",\"exclusionTrigger\":\"Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions\",\"inclusionTrigger\":\"\",\"dosages\":[{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.45nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"25mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.40nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"40mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.35nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.30nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"60mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.\n25nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"75mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.20nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"90mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.15nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"100mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.10nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"125mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.05nmol/L or lower\",\"exclusionTrigger\":\"\"}],\"description\":\"Testosterone therapy involves the administration of testosterone to treat conditions caused by low levels of testosterone such as hypogonadism. This treatment can be delivered via injections, transdermal patches, or gels, and aims to restore normal levels of testosterone, improving libido, energy, muscle mass, and bone density.\\n\\nIndications:\\n• Male hypogonadism\\n• Delayed puberty in boys\\n• Certain types of breast cancer in women\\n\\nContraindications:\\n• Prostate or breast cancer in men\\n• Severe liver disease\\n• Severe heart failure\\n\\nPotential Side Effects:\\n• Acne, skin irritation\\n• Increased risk of cardiovascular disease\\n• Liver abnormalities\\n• Mood Ideal level: 0,415-0,45 ng/dl\"}",
                  "relevance": 0.6155376,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_testosterone"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "397d01995cee4692ac727831b5c32891"
                    ],
                    "__file_part": [
                      "eb48b9b227be418785603d9a6e0acd23"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Testosterone"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_nebido_injection/aa06ba1de7124cfebf71aa348bf9da35",
              "index": "interventionsv1",
              "documentId": "medication_nebido_injection",
              "fileId": "aa06ba1de7124cfebf71aa348bf9da35",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_nebido_injection&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Nebido injection\",\"benefit\":\"\",\"objective\":\"Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)\",\"exclusionTrigger\":\"Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions\",\"inclusionTrigger\":\"Personal preference: convenience; not need to remember to take daily\",\"dosages\":[{\"dosage\":\"1000mg / 4ml\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}],\"description\":\"\"}",
                  "relevance": 0.5220659,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_nebido_injection"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "aa06ba1de7124cfebf71aa348bf9da35"
                    ],
                    "__file_part": [
                      "e83d9c840ecc45a8b3278d646eee3117"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Nebido injection"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_dhea/786ef7f065114e04bf01f6b88127d8c1",
              "index": "interventionsv1",
              "documentId": "medication_dhea",
              "fileId": "786ef7f065114e04bf01f6b88127d8c1",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_dhea&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"DHEA\",\"benefit\":\"\",\"objective\":\"Bring DHEA sulphate levels to an optimal range (6umol/L)\",\"exclusionTrigger\":\"DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.\n\",\"inclusionTrigger\":\"\",\"dosages\":[{\"dosage\":\"5mg\",\"inclusionTrigger\":\"When DHEA measurements are around 8umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When DHEA measurements are around 7umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"15mg\",\"inclusionTrigger\":\"When DHEA measurements are around 6umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"20mg\",\"inclusionTrigger\":\"When DHEA measurements are around 5umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"30mg\",\"inclusionTrigger\":\"When DHEA measurements are around 4umol/L or lower\",\"exclusionTrigger\":\n\"\"},{\"dosage\":\"35mg\",\"inclusionTrigger\":\"When DHEA measurements are around 3umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"45mg\",\"inclusionTrigger\":\"When DHEA measurements are around 2umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When DHEA measurements are around 1umol/L or lower\",\"exclusionTrigger\":\"\"}],\"description\":\"Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress.\nDHEA is administered orally.\\n\\nIndications:\\n• Adrenal insufficiency\\n• Depression\\n• Systemic lupus erythematosus (SLE)\\n• Aging skin\\n\\nContraindications:\\n• Cancer of the breast, ovaries, or prostate\\n• Severe liver disease\\n• Pregnancy\\n\\nPotential Side Effects:\\n• Oily skin and acne\\n• Hair loss\\n• Stomach upset\\n• High blood pressure\"}",
                  "relevance": 0.4286994,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_dhea"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "786ef7f065114e04bf01f6b88127d8c1"
                    ],
                    "__file_part": [
                      "e094cd664f42491cb13ee4cdfafb709e"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "DHEA"
                    ]
                  }
                }
              ]
            }
          ]
        }
      },
      {
        "json": {
          "query": "Explore dietary supplements that support energy levels and recovery in physically active individuals with a vegetarian-leaning diet.",
          "noResult": false,
          "results": [
            {
              "link": "interventionsv1/medication_dhea/786ef7f065114e04bf01f6b88127d8c1",
              "index": "interventionsv1",
              "documentId": "medication_dhea",
              "fileId": "786ef7f065114e04bf01f6b88127d8c1",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_dhea&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"DHEA\",\"benefit\":\"\",\"objective\":\"Bring DHEA sulphate levels to an optimal range (6umol/L)\",\"exclusionTrigger\":\"DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.\n\",\"inclusionTrigger\":\"\",\"dosages\":[{\"dosage\":\"5mg\",\"inclusionTrigger\":\"When DHEA measurements are around 8umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When DHEA measurements are around 7umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"15mg\",\"inclusionTrigger\":\"When DHEA measurements are around 6umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"20mg\",\"inclusionTrigger\":\"When DHEA measurements are around 5umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"30mg\",\"inclusionTrigger\":\"When DHEA measurements are around 4umol/L or lower\",\"exclusionTrigger\":\n\"\"},{\"dosage\":\"35mg\",\"inclusionTrigger\":\"When DHEA measurements are around 3umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"45mg\",\"inclusionTrigger\":\"When DHEA measurements are around 2umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When DHEA measurements are around 1umol/L or lower\",\"exclusionTrigger\":\"\"}],\"description\":\"Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress.\nDHEA is administered orally.\\n\\nIndications:\\n• Adrenal insufficiency\\n• Depression\\n• Systemic lupus erythematosus (SLE)\\n• Aging skin\\n\\nContraindications:\\n• Cancer of the breast, ovaries, or prostate\\n• Severe liver disease\\n• Pregnancy\\n\\nPotential Side Effects:\\n• Oily skin and acne\\n• Hair loss\\n• Stomach upset\\n• High blood pressure\"}",
                  "relevance": 0.384071,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_dhea"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "786ef7f065114e04bf01f6b88127d8c1"
                    ],
                    "__file_part": [
                      "e094cd664f42491cb13ee4cdfafb709e"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "DHEA"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_vitamine_d/5dba04b1b25a430dae97e45ea58a2314",
              "index": "interventionsv1",
              "documentId": "medication_vitamine_d",
              "fileId": "5dba04b1b25a430dae97e45ea58a2314",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_vitamine_d&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Vitamine D\",\"benefit\":\"\",\"objective\":\"Bring Vitamine 25(OH)D to optimal range of 175 nmol/L\",\"exclusionTrigger\":\"Absolute contraindications for vitamin D supplementation include hypercalcemia, sarcoidosis, tuberculosis, certain lymphomas, severe kidney disease or end-stage renal disease, hypervitaminosis D (vitamin D toxicity), and allergies to vitamin D or its additives.\",\"inclusionTrigger\":\"When Vitamine 25(OH)D is lower than 175 nmol/L in healthy men and 200 in men with chronic or autoinmune diseases\",\"dosages\":[{\"dosage\":\"4.000UI\",\"option\":\"Capsule\",\"frequency\":\"Daily\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"},{\"dosage\":\"300.000UI\",\"option\":\"Vial\",\"frequency\":\"4 vials every 8 weeks\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}],\"description\":\"Vitamin D is essential for bone health, immune function, and reduction of inflammation. It is typically administered orally to correct deficiencies, support bone health, and potentially prevent a range of chronic diseases.\\n\\nIndications:\\n• Vitamin D deficiency\\n• Osteoporosis\\n• Autoimmune disorders\\n• Prevention of certain cancers\\n\\nContraindications:\\n• Hypercalcemia\\n• Severe renal disease\\n\\nPotential Side Effects:\\n• Hypercalcemia if overdosed\\n• Nausea\\n• Fatigue\\n• Kidney stones\"}",
                  "relevance": 0.33513445,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_vitamine_d"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "5dba04b1b25a430dae97e45ea58a2314"
                    ],
                    "__file_part": [
                      "41bac7b1e88b43dc8a4d9c3e4fa2839b"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Vitamine D"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_testosterone/397d01995cee4692ac727831b5c32891",
              "index": "interventionsv1",
              "documentId": "medication_testosterone",
              "fileId": "397d01995cee4692ac727831b5c32891",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_testosterone&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Testosterone\",\"benefit\":\"\",\"objective\":\"Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)\",\"exclusionTrigger\":\"Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions\",\"inclusionTrigger\":\"\",\"dosages\":[{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.45nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"25mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.40nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"40mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.35nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.30nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"60mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.\n25nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"75mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.20nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"90mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.15nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"100mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.10nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"125mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.05nmol/L or lower\",\"exclusionTrigger\":\"\"}],\"description\":\"Testosterone therapy involves the administration of testosterone to treat conditions caused by low levels of testosterone such as hypogonadism. This treatment can be delivered via injections, transdermal patches, or gels, and aims to restore normal levels of testosterone, improving libido, energy, muscle mass, and bone density.\\n\\nIndications:\\n• Male hypogonadism\\n• Delayed puberty in boys\\n• Certain types of breast cancer in women\\n\\nContraindications:\\n• Prostate or breast cancer in men\\n• Severe liver disease\\n• Severe heart failure\\n\\nPotential Side Effects:\\n• Acne, skin irritation\\n• Increased risk of cardiovascular disease\\n• Liver abnormalities\\n• Mood Ideal level: 0,415-0,45 ng/dl\"}",
                  "relevance": 0.33482194,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_testosterone"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "397d01995cee4692ac727831b5c32891"
                    ],
                    "__file_part": [
                      "eb48b9b227be418785603d9a6e0acd23"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Testosterone"
                    ]
                  }
                }
              ]
            }
          ]
        }
      },
      {
        "json": {
          "query": "Investigate additional or alternative supplements compatible with Omega-3 and krill oil for cardiovascular and cognitive health in older adults.",
          "noResult": false,
          "results": [
            {
              "link": "interventionsv1/medication_dhea/786ef7f065114e04bf01f6b88127d8c1",
              "index": "interventionsv1",
              "documentId": "medication_dhea",
              "fileId": "786ef7f065114e04bf01f6b88127d8c1",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_dhea&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"DHEA\",\"benefit\":\"\",\"objective\":\"Bring DHEA sulphate levels to an optimal range (6umol/L)\",\"exclusionTrigger\":\"DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.\n\",\"inclusionTrigger\":\"\",\"dosages\":[{\"dosage\":\"5mg\",\"inclusionTrigger\":\"When DHEA measurements are around 8umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When DHEA measurements are around 7umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"15mg\",\"inclusionTrigger\":\"When DHEA measurements are around 6umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"20mg\",\"inclusionTrigger\":\"When DHEA measurements are around 5umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"30mg\",\"inclusionTrigger\":\"When DHEA measurements are around 4umol/L or lower\",\"exclusionTrigger\":\n\"\"},{\"dosage\":\"35mg\",\"inclusionTrigger\":\"When DHEA measurements are around 3umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"45mg\",\"inclusionTrigger\":\"When DHEA measurements are around 2umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When DHEA measurements are around 1umol/L or lower\",\"exclusionTrigger\":\"\"}],\"description\":\"Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress.\nDHEA is administered orally.\\n\\nIndications:\\n• Adrenal insufficiency\\n• Depression\\n• Systemic lupus erythematosus (SLE)\\n• Aging skin\\n\\nContraindications:\\n• Cancer of the breast, ovaries, or prostate\\n• Severe liver disease\\n• Pregnancy\\n\\nPotential Side Effects:\\n• Oily skin and acne\\n• Hair loss\\n• Stomach upset\\n• High blood pressure\"}",
                  "relevance": 0.32617128,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_dhea"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "786ef7f065114e04bf01f6b88127d8c1"
                    ],
                    "__file_part": [
                      "e094cd664f42491cb13ee4cdfafb709e"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "DHEA"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_pregnenolone/efeee20ad2cb4811a19ab7149abe4e8c",
              "index": "interventionsv1",
              "documentId": "medication_pregnenolone",
              "fileId": "efeee20ad2cb4811a19ab7149abe4e8c",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_pregnenolone&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Pregnenolone\",\"benefit\":\"Improve sleep & overall hormonal production\",\"objective\":\"Improve sleep and hormone production\",\"exclusionTrigger\":\"Pregnenolone supplementation should be absolutely avoided in individuals with hormone-sensitive cancers (such as breast, ovarian, uterine, or prostate cancer), as well as in those with conditions like endometriosis or uterine fibroids, due to its potential to influence hormone levels. Pregnant or breastfeeding women should also avoid pregnenolone, as its safety in these populations has not been established. People with bipolar disorder or other severe mental health disorders should avoid pregnenolone, as it may exacerbate mood instability or trigger manic episodes. Those with liver or kidney disease are advised against its use, given the body’s reliance on these organs for metabolizing pregnenolone, which could pose a risk.\nFinally, pregnenolone should not be taken by individuals on hormone therapies, such as birth control or hormone replacement therapy, due to potential interactions that could disrupt hormone balance.\",\"inclusionTrigger\":\"Sleep issues, stressfull lifestyle, works a lot, competitive environment\",\"dosages\":[{\"dosage\":\"30mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}],\"description\":\"Pregnenolone is a steroid hormone involved in the synthesis of other steroids, including DHEA and progesterone. It's administered orally and is thought to improve cognitive performance and memory, relieve symptoms of menopause, and enhance mood.\\n\\nIndications:\\n• Cognitive decline\\n• Mood disorders\\n• Hormonal imbalances\\n\\nContraindications:\\n• Hormone-sensitive cancers\\n• Severe liver or kidney disease\\n• History of seizures\\n\\nPotential Side Effects:\\n• Overstimulation and insomnia\\n• Mood swings\\n• Headaches\\n• Irregular heart rhythms\"}",
                  "relevance": 0.32565004,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_pregnenolone"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "efeee20ad2cb4811a19ab7149abe4e8c"
                    ],
                    "__file_part": [
                      "82d0671ffa884bf4ab268c9cae0763cc"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Pregnenolone"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_vitamine_d/5dba04b1b25a430dae97e45ea58a2314",
              "index": "interventionsv1",
              "documentId": "medication_vitamine_d",
              "fileId": "5dba04b1b25a430dae97e45ea58a2314",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_vitamine_d&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Vitamine D\",\"benefit\":\"\",\"objective\":\"Bring Vitamine 25(OH)D to optimal range of 175 nmol/L\",\"exclusionTrigger\":\"Absolute contraindications for vitamin D supplementation include hypercalcemia, sarcoidosis, tuberculosis, certain lymphomas, severe kidney disease or end-stage renal disease, hypervitaminosis D (vitamin D toxicity), and allergies to vitamin D or its additives.\",\"inclusionTrigger\":\"When Vitamine 25(OH)D is lower than 175 nmol/L in healthy men and 200 in men with chronic or autoinmune diseases\",\"dosages\":[{\"dosage\":\"4.000UI\",\"option\":\"Capsule\",\"frequency\":\"Daily\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"},{\"dosage\":\"300.000UI\",\"option\":\"Vial\",\"frequency\":\"4 vials every 8 weeks\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}],\"description\":\"Vitamin D is essential for bone health, immune function, and reduction of inflammation. It is typically administered orally to correct deficiencies, support bone health, and potentially prevent a range of chronic diseases.\\n\\nIndications:\\n• Vitamin D deficiency\\n• Osteoporosis\\n• Autoimmune disorders\\n• Prevention of certain cancers\\n\\nContraindications:\\n• Hypercalcemia\\n• Severe renal disease\\n\\nPotential Side Effects:\\n• Hypercalcemia if overdosed\\n• Nausea\\n• Fatigue\\n• Kidney stones\"}",
                  "relevance": 0.28580552,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_vitamine_d"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "5dba04b1b25a430dae97e45ea58a2314"
                    ],
                    "__file_part": [
                      "41bac7b1e88b43dc8a4d9c3e4fa2839b"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Vitamine D"
                    ]
                  }
                }
              ]
            }
          ]
        }
      },
      {
        "json": {
          "query": "Locate preventive strategies or therapies for individuals at risk of atrial fibrillation, focusing on those with a family history and stress-related lifestyle factors.",
          "noResult": false,
          "results": [
            {
              "link": "interventionsv1/medication_pregnenolone/efeee20ad2cb4811a19ab7149abe4e8c",
              "index": "interventionsv1",
              "documentId": "medication_pregnenolone",
              "fileId": "efeee20ad2cb4811a19ab7149abe4e8c",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_pregnenolone&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Pregnenolone\",\"benefit\":\"Improve sleep & overall hormonal production\",\"objective\":\"Improve sleep and hormone production\",\"exclusionTrigger\":\"Pregnenolone supplementation should be absolutely avoided in individuals with hormone-sensitive cancers (such as breast, ovarian, uterine, or prostate cancer), as well as in those with conditions like endometriosis or uterine fibroids, due to its potential to influence hormone levels. Pregnant or breastfeeding women should also avoid pregnenolone, as its safety in these populations has not been established. People with bipolar disorder or other severe mental health disorders should avoid pregnenolone, as it may exacerbate mood instability or trigger manic episodes. Those with liver or kidney disease are advised against its use, given the body’s reliance on these organs for metabolizing pregnenolone, which could pose a risk.\nFinally, pregnenolone should not be taken by individuals on hormone therapies, such as birth control or hormone replacement therapy, due to potential interactions that could disrupt hormone balance.\",\"inclusionTrigger\":\"Sleep issues, stressfull lifestyle, works a lot, competitive environment\",\"dosages\":[{\"dosage\":\"30mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}],\"description\":\"Pregnenolone is a steroid hormone involved in the synthesis of other steroids, including DHEA and progesterone. It's administered orally and is thought to improve cognitive performance and memory, relieve symptoms of menopause, and enhance mood.\\n\\nIndications:\\n• Cognitive decline\\n• Mood disorders\\n• Hormonal imbalances\\n\\nContraindications:\\n• Hormone-sensitive cancers\\n• Severe liver or kidney disease\\n• History of seizures\\n\\nPotential Side Effects:\\n• Overstimulation and insomnia\\n• Mood swings\\n• Headaches\\n• Irregular heart rhythms\"}",
                  "relevance": 0.22378246,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_pregnenolone"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "efeee20ad2cb4811a19ab7149abe4e8c"
                    ],
                    "__file_part": [
                      "82d0671ffa884bf4ab268c9cae0763cc"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Pregnenolone"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_anastrozole/df4c386fa53c4b38bffdfe37b7464731",
              "index": "interventionsv1",
              "documentId": "medication_anastrozole",
              "fileId": "df4c386fa53c4b38bffdfe37b7464731",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_anastrozole&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"Anastrozole\",\"benefit\":\"\",\"objective\":\"Help reduce weight and improve mood\",\"exclusionTrigger\":\"\",\"inclusionTrigger\":\"Gynecomastia & Obesity, lack of confidence\",\"dosages\":[{\"dosage\":\"1mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}],\"description\":\"Anastrozole is an aromatase inhibitor used primarily to treat breast cancer in postmenopausal women. It works by lowering estrogen hormone levels to help shrink tumors and slow tumor growth. Anastrozole is taken orally.\\n\\nIndications:\\n• Breast cancer in postmenopausal women\\n• Adjuvant treatment of early breast cancer\\n• First-line treatment of locally advanced or metastatic breast cancer\\n\\nContraindications:\\n• Pre-existing heart conditions\\n• Osteoporosis\\n• Pre-menopausal women\\n\\nPotential Side Effects:\\n• Increased risk of fractures\\n• Joint pain\\n• Nausea\\n• Weakness\"}",
                  "relevance": 0.21380493,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_anastrozole"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "df4c386fa53c4b38bffdfe37b7464731"
                    ],
                    "__file_part": [
                      "e98c918003174c6c91ec3906d3963f9a"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "Anastrozole"
                    ]
                  }
                }
              ]
            },
            {
              "link": "interventionsv1/medication_dhea/786ef7f065114e04bf01f6b88127d8c1",
              "index": "interventionsv1",
              "documentId": "medication_dhea",
              "fileId": "786ef7f065114e04bf01f6b88127d8c1",
              "sourceContentType": "application/json",
              "sourceName": "file.json",
              "sourceUrl": "/download?index=interventionsv1&documentId=medication_dhea&filename=file.json",
              "partitions": [
                {
                  "text": "{\"name\":\"DHEA\",\"benefit\":\"\",\"objective\":\"Bring DHEA sulphate levels to an optimal range (6umol/L)\",\"exclusionTrigger\":\"DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.\n\",\"inclusionTrigger\":\"\",\"dosages\":[{\"dosage\":\"5mg\",\"inclusionTrigger\":\"When DHEA measurements are around 8umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When DHEA measurements are around 7umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"15mg\",\"inclusionTrigger\":\"When DHEA measurements are around 6umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"20mg\",\"inclusionTrigger\":\"When DHEA measurements are around 5umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"30mg\",\"inclusionTrigger\":\"When DHEA measurements are around 4umol/L or lower\",\"exclusionTrigger\":\n\"\"},{\"dosage\":\"35mg\",\"inclusionTrigger\":\"When DHEA measurements are around 3umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"45mg\",\"inclusionTrigger\":\"When DHEA measurements are around 2umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When DHEA measurements are around 1umol/L or lower\",\"exclusionTrigger\":\"\"}],\"description\":\"Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress.\nDHEA is administered orally.\\n\\nIndications:\\n• Adrenal insufficiency\\n• Depression\\n• Systemic lupus erythematosus (SLE)\\n• Aging skin\\n\\nContraindications:\\n• Cancer of the breast, ovaries, or prostate\\n• Severe liver disease\\n• Pregnancy\\n\\nPotential Side Effects:\\n• Oily skin and acne\\n• Hair loss\\n• Stomach upset\\n• High blood pressure\"}",
                  "relevance": 0.20488256,
                  "partitionNumber": 0,
                  "sectionNumber": 0,
                  "lastUpdate": "2024-12-18T11:39:46+00:00",
                  "tags": {
                    "__document_id": [
                      "medication_dhea"
                    ],
                    "__file_type": [
                      "application/json"
                    ],
                    "__file_id": [
                      "786ef7f065114e04bf01f6b88127d8c1"
                    ],
                    "__file_part": [
                      "e094cd664f42491cb13ee4cdfafb709e"
                    ],
                    "__part_n": [
                      "0"
                    ],
                    "__sect_n": [
                      "0"
                    ],
                    "pathwayUrl": [
                      "https://fhir.aera.health/fhir/R4/PlanDefinition/2124af55-22b3-44e3-abeb-dfa750e3ea41"
                    ],
                    "name": [
                      "DHEA"
                    ]
                  }
                }
              ]
            }
          ]
        }
      }
    ],
    "Match and Validate Try 0": [
      {
        "json": {
          "originItem": {
            "name": "Testosterone",
            "phase": "Diagnosis confirmed",
            "url": "https://fhir.aera.health/fhir/R4/ActivityDefinition/399d2e94-ee03-4354-a0b0-9d0b15246b53",
            "type": "Treatment",
            "symptoms": [
              "Reduced sex drive",
              "Reduced erectile function",
              "Loss of body hair",
              "Less beard growth",
              "Loss of lean muscle mass",
              "Fatigue",
              "Obesity",
              "Symptoms of depression"
            ],
            "objective": "Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)",
            "inclusionTrigger": "",
            "exclusionTrigger": "Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions",
            "options": [
              "Rapid Disolving Tablets",
              "Lozenges",
              "Sublingual drops"
            ],
            "frequency": "Daily at 9:00 AM",
            "dossingInstructions": "Begin with 50% of optimal dose for first 2 weeks afterwards normal dose, -20% for RDTs, Lozenges & Sublingual Drops",
            "review": "3 months",
            "benefit": "",
            "supportingActivities": "",
            "description": "Testosterone therapy involves the administration of testosterone to treat conditions caused by low levels of testosterone such as hypogonadism. This treatment can be delivered via injections, transdermal patches, or gels, and aims to restore normal levels of testosterone, improving libido, energy, muscle mass, and bone density.\n\nIndications:\n• Male hypogonadism\n• Delayed puberty in boys\n• Certain types of breast cancer in women\n\nContraindications:\n• Prostate or breast cancer in men\n• Severe liver disease\n• Severe heart failure\n\nPotential Side Effects:\n• Acne, skin irritation\n• Increased risk of cardiovascular disease\n• Liver abnormalities\n• Mood Ideal level: 0,415-0,45 ng/dl",
            "dosages": [
              {
                "dosage": "10mg",
                "inclusionTrigger": "When Free Testosterone level is 0.45nmol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "25mg",
                "inclusionTrigger": "When Free Testosterone level is 0.40nmol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "40mg",
                "inclusionTrigger": "When Free Testosterone level is 0.35nmol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "50mg",
                "inclusionTrigger": "When Free Testosterone level is 0.30nmol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "60mg",
                "inclusionTrigger": "When Free Testosterone level is 0.25nmol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "75mg",
                "inclusionTrigger": "When Free Testosterone level is 0.20nmol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "90mg",
                "inclusionTrigger": "When Free Testosterone level is 0.15nmol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "100mg",
                "inclusionTrigger": "When Free Testosterone level is 0.10nmol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "125mg",
                "inclusionTrigger": "When Free Testosterone level is 0.05nmol/L or lower",
                "exclusionTrigger": ""
              }
            ]
          },
          "matchResult": {
            "isRecommended": false,
            "recommendationReason": "",
            "notRecommendationReason": "The patient does not meet the inclusion criteria for testosterone supplementation, as free testosterone levels (8.2 pg/ml) do not fall within the lower range required for treatment. No dosage is applicable.",
            "option": "",
            "dosage": {
              "dosage": "",
              "recommendationReason": ""
            }
          },
          "matchedDosage": null,
          "validationResults": [
            {
              "retry": 0,
              "isValid": true,
              "reasons": [
                "The patient's free testosterone level is reported as 8.2 pg/ml, which is within the normal reference range (5.0 - 21.0 pg/ml) and does not meet the inclusion criteria for testosterone therapy, which require levels of 0.45 nmol/L or lower.",
                "There are no reported exclusion criteria such as prostate or male breast cancer, severe untreated sleep apnea, or other conditions that would contraindicate testosterone therapy.",
                "The output correctly identifies that testosterone therapy is not applicable for the patient due to the free testosterone levels not meeting the inclusion criteria."
              ]
            }
          ],
          "history": [
            {
              "role": "system",
              "content": "You are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both `inclusionTrigger` and `exclusionTrigger` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as `objective`, `benefit`, `supportingActivities` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the `dosages` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if `options` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n{\"json\":{\"originItem\":{\"name\":\"Testosterone\",\"phase\":\"Diagnosis confirmed\",\"url\":\"https://fhir.aera.health/fhir/R4/ActivityDefinition/399d2e94-ee03-4354-a0b0-9d0b15246b53\",\"type\":\"Treatment\",\"symptoms\":[\"Reduced sex drive\",\"Reduced erectile function\",\"Loss of body hair\",\"Less beard growth\",\"Loss of lean muscle mass\",\"Fatigue\",\"Obesity\",\"Symptoms of depression\"],\"objective\":\"Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions\",\"options\":[\"Rapid Disolving Tablets\",\"Lozenges\",\"Sublingual drops\"],\"frequency\":\"Daily at 9:00 AM\",\"dossingInstructions\":\"Begin with 50% of optimal dose for first 2 weeks afterwards normal dose, -20% for RDTs, Lozenges & Sublingual Drops\",\"review\":\"3 months\",\"benefit\":\"\",\"supportingActivities\":\"\",\"description\":\"Testosterone therapy involves the administration of testosterone to treat conditions caused by low levels of testosterone such as hypogonadism. This treatment can be delivered via injections, transdermal patches, or gels, and aims to restore normal levels of testosterone, improving libido, energy, muscle mass, and bone density.\\n\\nIndications:\\n• Male hypogonadism\\n• Delayed puberty in boys\\n• Certain types of breast cancer in women\\n\\nContraindications:\\n• Prostate or breast cancer in men\\n• Severe liver disease\\n• Severe heart failure\\n\\nPotential Side Effects:\\n• Acne, skin irritation\\n• Increased risk of cardiovascular disease\\n• Liver abnormalities\\n• Mood Ideal level: 0,415-0,45 ng/dl\",\"dosages\":[{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.45nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"25mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.40nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"40mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.35nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.30nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"60mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.25nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"75mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.20nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"90mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.15nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"100mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.10nmol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"125mg\",\"inclusionTrigger\":\"When Free Testosterone level is 0.05nmol/L or lower\",\"exclusionTrigger\":\"\"}]},\"matchResult\":null,\"matchedDosage\":null,\"validationResults\":[],\"history\":[]},\"pairedItem\":{\"item\":0}}"
            },
            {
              "role": "user",
              "content": "### **Patient data:**\n\n# Patient profile\n\n      # Patient profile\r\n\r\n- Age: 58\r\n- DOB: 1966\r\n- Gender: male\r\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\r\n\r\n---\r\n\r\n# Social  \r\n\r\n**Date: 12/02/2020**  \r\n- otherwise well  \r\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \r\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \r\n\r\n**Date: 10/09/2018**  \r\n- Ex-Cigar Smoker  \r\n\r\n**Date: 11/05/2017**  \r\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \r\n- Non-smoker  \r\n- 3-4 times a week  \r\n- 1-2 hours per week  \r\n- company director  \r\n- Smoked for 28 years, 20 a day, 28 pack day history  \r\n- Married  \r\n- Light drinker - 1-2u/day  \r\n\r\n---\r\n\r\n# Medical history  \r\n\r\n**Date: 07/06/2023**  \r\n- Discussed sharing records with NHS practice  \r\n\r\n**Date: 25/03/2023**  \r\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \r\n\r\n**Date: 01/11/2021**  \r\n- Systolic BP: 110  \r\n- Diastolic BP: 72  \r\n\r\n**Date: 10/02/2021**  \r\n- Weight: 90.2  \r\n- BMI: 28.47  \r\n\r\n**Date: 05/12/2020**  \r\n- Blood Pressure: 121.78  \r\n\r\n**Date: 12/02/2020**  \r\n- Height: 178  \r\n\r\n**Date: 10/09/2018**  \r\n- Pulse: 77  \r\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \r\n\r\n**Date: 27/10/2017**  \r\n- Blood Oxygen: 97  \r\n- lungs clear, good a/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \r\n\r\n---\r\n\r\n# Medication  \r\n\r\n**Date: 12/02/2020**  \r\n- Omega 3 and Krill oil\r\n\r\n**Date: 10/09/2018**  \r\n- aspirin 75mg  \r\n\r\n**Date: 05/01/2017**  \r\n- nil  \r\n\r\n---\r\n\r\n# Family history  \r\n\r\n**Date: 10/09/2018**  \r\n- Younger brother recently Dx AF at 47yo  \r\n\r\n**Date: 11/05/2017**  \r\n- Unsure of who father is  \r\n- Mum: 75 years old - OA  \r\n- Has two brothers  \r\n- Brothers have no medical problems  \r\n- Mum has AF  \r\n- Brother-in-law: Prostate cancer  \r\n\r\n---\r\n\r\n# Allergy  \r\n\r\n**Date: 05/01/2017**  \r\n- NKDA\r\n\n\n      ---\n      \n    \n      # Blood test results\n    \n      {\"date\":\"05/06/2023\",\"results\":[{\"test\":\"HAEMOGLOBIN\",\"range\":\"130 - 170\",\"unit\":\"g/L\",\"value\":147},{\"test\":\"HCT\",\"range\":\"0.37 - 0.50\",\"value\":0.448},{\"test\":\"RED CELL COUNT\",\"range\":\"4.40 - 5.80\",\"unit\":\"x10^12/L\",\"value\":4.78},{\"test\":\"MCV\",\"range\":\"80 - 99\",\"unit\":\"fL\",\"value\":93.7},{\"test\":\"MCH\",\"range\":\"27.0 - 33.5\",\"unit\":\"pg\",\"value\":30.8},{\"test\":\"MCHC\",\"range\":\"300 - 350\",\"unit\":\"g/L\",\"value\":328},{\"test\":\"RDW\",\"range\":\"11.5 - 15.0\",\"value\":12},{\"test\":\"PLATELET COUNT\",\"range\":\"150 - 400\",\"unit\":\"x10^9/L\",\"value\":174},{\"test\":\"MPV\",\"range\":\"7 - 13\",\"unit\":\"fL\",\"value\":10.9},{\"test\":\"WHITE CELL COUNT\",\"range\":\"3.0 - 10.0\",\"unit\":\"x10^9/L\",\"value\":5.95},{\"test\":\"Neutrophils\",\"range\":\"2.0 - 7.5\",\"unit\":\"x10^9/L\",\"value\":3.43,\"percentage\":57.6},{\"test\":\"Lymphocytes\",\"range\":\"1.2 - 3.65\",\"unit\":\"x10^9/L\",\"value\":2.02,\"percentage\":33.9},{\"test\":\"Monocytes\",\"range\":\"0.2 - 1.0\",\"unit\":\"x10^9/L\",\"value\":0.44,\"percentage\":7.4},{\"test\":\"Eosinophils\",\"range\":\"0.0 - 0.4\",\"unit\":\"x10^9/L\",\"value\":0.05,\"percentage\":0.8},{\"test\":\"Basophils\",\"range\":\"0.0 - 0.1\",\"unit\":\"x10^9/L\",\"value\":0.02,\"percentage\":0.3},{\"test\":\"ALBUMIN\",\"range\":\"34 - 50\",\"unit\":\"g/L\",\"value\":46},{\"test\":\"Prostate Specific Ag (Total)\",\"range\":\"0.00 - 2.99\",\"unit\":\"ug/L\",\"value\":0.29},{\"test\":\"FOLLICLE STIM. HORMONE\",\"range\":\"1.5 - 12.4\",\"unit\":\"IU/L\",\"value\":3.3},{\"test\":\"LUTEINISING HORMONE\",\"range\":\"1.7 - 8.6\",\"unit\":\"IU/L\",\"value\":2.5},{\"test\":\"PROGESTERONE\",\"range\":\"0.2 - 0.5\",\"unit\":\"nmol/L\",\"value\":0.5},{\"test\":\"TESTOSTERONE\",\"range\":\"7.6 - 31.4\",\"unit\":\"nmol/L\",\"value\":20.8},{\"test\":\"SEX HORMONE BINDING GLOB\",\"range\":\"19 - 83\",\"unit\":\"nmol/L\",\"value\":70},{\"test\":\"PROLACTIN\",\"range\":\"86 - 324\",\"unit\":\"mIU/L\",\"value\":113},{\"test\":\"17-Beta OESTRADIOL\",\"range\":\"< 192\",\"unit\":\"pmol/L\",\"value\":81},{\"test\":\"D.H.E.A. Sulphate\",\"range\":\"0.44 - 13.4\",\"unit\":\"umol/L\",\"value\":5.7},{\"test\":\"Free Testosterone\",\"range\":\"5.0 - 21.0\",\"unit\":\"pg/ml\",\"value\":8.2},{\"test\":\"Dihydrotestosterone\",\"range\":\"0.33 - 3.01\",\"unit\":\"nmol/L\",\"value\":1.61}]}\n\n      ---"
            },
            {
              "role": "assistant",
              "content": "**Evaluation for Testosterone Therapy:**\n\n1. **Inclusion Criteria:**\n   - Free Testosterone Level: The patient's free testosterone level is 8.2 pg/ml. A conversion of this value might be necessary to compare with the given criteria in nmol/L, but generally, 8.2 pg/ml falls well within the normal reference range (5.0 - 21.0 pg/ml). The inclusion criteria for dosage are based on testosterone levels of 0.45 nmol/L or lower; therefore, this patient's levels do not meet the condition for treatment based on the inclusion criteria.\n\n2. **Exclusion Criteria:**\n   - The patient does not report any prostate or male breast cancer, severe untreated sleep apnea, severe heart failure, or allergies to testosterone formulations.\n   - The prostate-specific antigen (PSA) level is 0.29 ug/L, well within normal limits, indicating no known prostate issues at present. There is also no indication of uncontrolled hypertension or high hematocrit levels.\n\n3. **Summary and Decision:**\n   - Based on the provided data, the patient does not meet the inclusion criteria for testosterone supplementation, as free testosterone levels do not fall within the lower range required for treatment. Additionally, despite the lack of exclusion criteria, treatment is not recommended without qualifying inclusion criteria.\n   - No dosage is applicable as the patient doesn't fit the inclusion triggers.\n\n**Conclusion:**\nTestosterone therapy is not applicable to this patient as the current testosterone levels do not indicate hypogonadism or a related condition that requires treatment. Furthermore, the patient is free of exclusion criteria conditions that would pose a risk for testosterone therapy, but the primary reason is the non-eligibility based on testosterone levels. It's advised to maintain regular monitoring and reevaluation of hormone levels if symptoms persist or change."
            }
          ]
        }
      },
      {
        "json": {
          "originItem": {
            "name": "DHEA",
            "phase": "Diagnosis confirmed",
            "url": "https://fhir.aera.health/fhir/R4/ActivityDefinition/e03cdbbf-b2e8-437a-a0e0-3bf1d302dffe",
            "type": "Treatment",
            "symptoms": [
              "Obesity",
              "Erectile disfunction",
              "Adrenal insuficiency"
            ],
            "objective": "Bring DHEA sulphate levels to an optimal range (6umol/L)",
            "inclusionTrigger": "",
            "exclusionTrigger": "DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.",
            "options": [
              "Capsules",
              "Rapid Disolving Tablets",
              "Lozenges",
              "Sublingual drops"
            ],
            "frequency": "Daily at 7:00 AM",
            "dossingInstructions": "Begin with 50% of optimal dose for first 2 weeks afterwards normal dose, -20% for RDTs, Lozenges & Sublingual Drops",
            "review": "3 months",
            "benefit": "",
            "supportingActivities": "",
            "description": "Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress. DHEA is administered orally.\n\nIndications:\n• Adrenal insufficiency\n• Depression\n• Systemic lupus erythematosus (SLE)\n• Aging skin\n\nContraindications:\n• Cancer of the breast, ovaries, or prostate\n• Severe liver disease\n• Pregnancy\n\nPotential Side Effects:\n• Oily skin and acne\n• Hair loss\n• Stomach upset\n• High blood pressure",
            "dosages": [
              {
                "dosage": "5mg",
                "inclusionTrigger": "When DHEA measurements are around 8umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "10mg",
                "inclusionTrigger": "When DHEA measurements are around 7umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "15mg",
                "inclusionTrigger": "When DHEA measurements are around 6umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "20mg",
                "inclusionTrigger": "When DHEA measurements are around 5umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "30mg",
                "inclusionTrigger": "When DHEA measurements are around 4umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "35mg",
                "inclusionTrigger": "When DHEA measurements are around 3umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "45mg",
                "inclusionTrigger": "When DHEA measurements are around 2umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "50mg",
                "inclusionTrigger": "When DHEA measurements are around 1umol/L or lower",
                "exclusionTrigger": ""
              }
            ]
          },
          "matchResult": {
            "isRecommended": true,
            "recommendationReason": "The patient's DHEA Sulphate level is 5.7 umol/L, which qualifies for dosages up to 20 mg. There are no conflicting exclusion criteria such as high blood pressure, hormone-sensitive cancers, or mood disorders. Therefore, DHEA supplementation is recommended.",
            "notRecommendationReason": "",
            "option": "Capsules",
            "dosage": {
              "dosage": "20 mg",
              "recommendationReason": "20 mg is the smallest effective dosage that addresses the patient's current DHEA level of 5.7 umol/L according to the medication guidelines."
            }
          },
          "validationResults": [
            {
              "retry": 0,
              "isValid": false,
              "reasons": [
                "The OUTPUT incorrectly states that the smallest effective dosage for the patient's DHEA level (5.7 umol/L) is 20 mg, whereas it should correctly be 5 mg, which accommodates levels of 8 umol/L or lower.",
                "The statement regarding dosage eligibility overlooks the fact that the 5 mg dosage is suitable even though the patient qualifies for dosages of 20 mg or lower. The faithful output should suggest the smallest suitable dosage, which is 5 mg."
              ]
            }
          ],
          "history": [
            {
              "role": "system",
              "content": "You are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both `inclusionTrigger` and `exclusionTrigger` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as `objective`, `benefit`, `supportingActivities` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the `dosages` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if `options` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n{\"json\":{\"originItem\":{\"name\":\"DHEA\",\"phase\":\"Diagnosis confirmed\",\"url\":\"https://fhir.aera.health/fhir/R4/ActivityDefinition/e03cdbbf-b2e8-437a-a0e0-3bf1d302dffe\",\"type\":\"Treatment\",\"symptoms\":[\"Obesity\",\"Erectile disfunction\",\"Adrenal insuficiency\"],\"objective\":\"Bring DHEA sulphate levels to an optimal range (6umol/L)\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.\",\"options\":[\"Capsules\",\"Rapid Disolving Tablets\",\"Lozenges\",\"Sublingual drops\"],\"frequency\":\"Daily at 7:00 AM\",\"dossingInstructions\":\"Begin with 50% of optimal dose for first 2 weeks afterwards normal dose, -20% for RDTs, Lozenges & Sublingual Drops\",\"review\":\"3 months\",\"benefit\":\"\",\"supportingActivities\":\"\",\"description\":\"Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress. DHEA is administered orally.\\n\\nIndications:\\n• Adrenal insufficiency\\n• Depression\\n• Systemic lupus erythematosus (SLE)\\n• Aging skin\\n\\nContraindications:\\n• Cancer of the breast, ovaries, or prostate\\n• Severe liver disease\\n• Pregnancy\\n\\nPotential Side Effects:\\n• Oily skin and acne\\n• Hair loss\\n• Stomach upset\\n• High blood pressure\",\"dosages\":[{\"dosage\":\"5mg\",\"inclusionTrigger\":\"When DHEA measurements are around 8umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When DHEA measurements are around 7umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"15mg\",\"inclusionTrigger\":\"When DHEA measurements are around 6umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"20mg\",\"inclusionTrigger\":\"When DHEA measurements are around 5umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"30mg\",\"inclusionTrigger\":\"When DHEA measurements are around 4umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"35mg\",\"inclusionTrigger\":\"When DHEA measurements are around 3umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"45mg\",\"inclusionTrigger\":\"When DHEA measurements are around 2umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When DHEA measurements are around 1umol/L or lower\",\"exclusionTrigger\":\"\"}]},\"matchResult\":null,\"matchedDosage\":null,\"validationResults\":[],\"history\":[]},\"pairedItem\":{\"item\":1}}"
            },
            {
              "role": "user",
              "content": "### **Patient data:**\n\n# Patient profile\n\n      # Patient profile\r\n\r\n- Age: 58\r\n- DOB: 1966\r\n- Gender: male\r\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\r\n\r\n---\r\n\r\n# Social  \r\n\r\n**Date: 12/02/2020**  \r\n- otherwise well  \r\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \r\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \r\n\r\n**Date: 10/09/2018**  \r\n- Ex-Cigar Smoker  \r\n\r\n**Date: 11/05/2017**  \r\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \r\n- Non-smoker  \r\n- 3-4 times a week  \r\n- 1-2 hours per week  \r\n- company director  \r\n- Smoked for 28 years, 20 a day, 28 pack day history  \r\n- Married  \r\n- Light drinker - 1-2u/day  \r\n\r\n---\r\n\r\n# Medical history  \r\n\r\n**Date: 07/06/2023**  \r\n- Discussed sharing records with NHS practice  \r\n\r\n**Date: 25/03/2023**  \r\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \r\n\r\n**Date: 01/11/2021**  \r\n- Systolic BP: 110  \r\n- Diastolic BP: 72  \r\n\r\n**Date: 10/02/2021**  \r\n- Weight: 90.2  \r\n- BMI: 28.47  \r\n\r\n**Date: 05/12/2020**  \r\n- Blood Pressure: 121.78  \r\n\r\n**Date: 12/02/2020**  \r\n- Height: 178  \r\n\r\n**Date: 10/09/2018**  \r\n- Pulse: 77  \r\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \r\n\r\n**Date: 27/10/2017**  \r\n- Blood Oxygen: 97  \r\n- lungs clear, good a/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \r\n\r\n---\r\n\r\n# Medication  \r\n\r\n**Date: 12/02/2020**  \r\n- Omega 3 and Krill oil\r\n\r\n**Date: 10/09/2018**  \r\n- aspirin 75mg  \r\n\r\n**Date: 05/01/2017**  \r\n- nil  \r\n\r\n---\r\n\r\n# Family history  \r\n\r\n**Date: 10/09/2018**  \r\n- Younger brother recently Dx AF at 47yo  \r\n\r\n**Date: 11/05/2017**  \r\n- Unsure of who father is  \r\n- Mum: 75 years old - OA  \r\n- Has two brothers  \r\n- Brothers have no medical problems  \r\n- Mum has AF  \r\n- Brother-in-law: Prostate cancer  \r\n\r\n---\r\n\r\n# Allergy  \r\n\r\n**Date: 05/01/2017**  \r\n- NKDA\r\n\n\n      ---\n      \n    \n      # Blood test results\n    \n      {\"date\":\"05/06/2023\",\"results\":[{\"test\":\"HAEMOGLOBIN\",\"range\":\"130 - 170\",\"unit\":\"g/L\",\"value\":147},{\"test\":\"HCT\",\"range\":\"0.37 - 0.50\",\"value\":0.448},{\"test\":\"RED CELL COUNT\",\"range\":\"4.40 - 5.80\",\"unit\":\"x10^12/L\",\"value\":4.78},{\"test\":\"MCV\",\"range\":\"80 - 99\",\"unit\":\"fL\",\"value\":93.7},{\"test\":\"MCH\",\"range\":\"27.0 - 33.5\",\"unit\":\"pg\",\"value\":30.8},{\"test\":\"MCHC\",\"range\":\"300 - 350\",\"unit\":\"g/L\",\"value\":328},{\"test\":\"RDW\",\"range\":\"11.5 - 15.0\",\"value\":12},{\"test\":\"PLATELET COUNT\",\"range\":\"150 - 400\",\"unit\":\"x10^9/L\",\"value\":174},{\"test\":\"MPV\",\"range\":\"7 - 13\",\"unit\":\"fL\",\"value\":10.9},{\"test\":\"WHITE CELL COUNT\",\"range\":\"3.0 - 10.0\",\"unit\":\"x10^9/L\",\"value\":5.95},{\"test\":\"Neutrophils\",\"range\":\"2.0 - 7.5\",\"unit\":\"x10^9/L\",\"value\":3.43,\"percentage\":57.6},{\"test\":\"Lymphocytes\",\"range\":\"1.2 - 3.65\",\"unit\":\"x10^9/L\",\"value\":2.02,\"percentage\":33.9},{\"test\":\"Monocytes\",\"range\":\"0.2 - 1.0\",\"unit\":\"x10^9/L\",\"value\":0.44,\"percentage\":7.4},{\"test\":\"Eosinophils\",\"range\":\"0.0 - 0.4\",\"unit\":\"x10^9/L\",\"value\":0.05,\"percentage\":0.8},{\"test\":\"Basophils\",\"range\":\"0.0 - 0.1\",\"unit\":\"x10^9/L\",\"value\":0.02,\"percentage\":0.3},{\"test\":\"ALBUMIN\",\"range\":\"34 - 50\",\"unit\":\"g/L\",\"value\":46},{\"test\":\"Prostate Specific Ag (Total)\",\"range\":\"0.00 - 2.99\",\"unit\":\"ug/L\",\"value\":0.29},{\"test\":\"FOLLICLE STIM. HORMONE\",\"range\":\"1.5 - 12.4\",\"unit\":\"IU/L\",\"value\":3.3},{\"test\":\"LUTEINISING HORMONE\",\"range\":\"1.7 - 8.6\",\"unit\":\"IU/L\",\"value\":2.5},{\"test\":\"PROGESTERONE\",\"range\":\"0.2 - 0.5\",\"unit\":\"nmol/L\",\"value\":0.5},{\"test\":\"TESTOSTERONE\",\"range\":\"7.6 - 31.4\",\"unit\":\"nmol/L\",\"value\":20.8},{\"test\":\"SEX HORMONE BINDING GLOB\",\"range\":\"19 - 83\",\"unit\":\"nmol/L\",\"value\":70},{\"test\":\"PROLACTIN\",\"range\":\"86 - 324\",\"unit\":\"mIU/L\",\"value\":113},{\"test\":\"17-Beta OESTRADIOL\",\"range\":\"< 192\",\"unit\":\"pmol/L\",\"value\":81},{\"test\":\"D.H.E.A. Sulphate\",\"range\":\"0.44 - 13.4\",\"unit\":\"umol/L\",\"value\":5.7},{\"test\":\"Free Testosterone\",\"range\":\"5.0 - 21.0\",\"unit\":\"pg/ml\",\"value\":8.2},{\"test\":\"Dihydrotestosterone\",\"range\":\"0.33 - 3.01\",\"unit\":\"nmol/L\",\"value\":1.61}]}\n\n      ---"
            },
            {
              "role": "assistant",
              "content": "### Evaluation of Medication Criteria for DHEA Supplementation\n\n**Patient's Inclusion Criteria Confirmation:**\n\n1. **DHEA Sulphate Level:**\n   - **Current Level:** 5.7 umol/L \n   - **Inclusion Triggers:** Patients with measurements around 8 umol/L or lower are eligible for dosages. This patient qualifies for dosages at least until 20 mg since his DHEA level (5.7 umol/L) meets criteria up to 20 mg.\n\n**Exclusion Criteria Check:**\n\n- The exclusion criteria include hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or certain medications.\n- **Review of Patient's Data:**\n  - No evidence of hormone-sensitive cancers from the medical history.\n  - No indication of mood disorders or liver/kidney disease. Blood test results support normal organ function.\n  - The blood pressure readings (110/72 mmHg and 121/78 mmHg) are within normal ranges, ruling out hypertension.\n  - No medical history indicating PCOS, adrenal issues, diabetes, or related contraindicating medications.\n\n### Dosage Selection\n\n- **Eligible Dosages Based on Current DHEA Level (5.7 umol/L):**\n  - 5 mg, 10 mg, 15 mg, 20 mg.\n- **Smallest Effective Dosage:** The smallest effective dosage for the current DHEA level is 20 mg, as this dosage directly addresses levels around 5 umol/L or lower.\n\n### Medication Option and Form Selection\n\n- **Options Available:** Capsules, Rapid Dissolving Tablets (RDTs), Lozenges, Sublingual drops\n- **Form Decision:**\n  - Preferences based on convenience or patient preference for administration can guide the choice among available forms.\n  - **Suggested Form:** Capsules - a common form and potentially more acceptable given the wide use.\n\nBased on the assessment, the suitable dosage is **20 mg** with the **Capsule** form as a standard option unless otherwise directed by patient preference. This dosage aligns with the necessity to maintain DHEA levels at an optimal range without exceeding contraindicating thresholds."
            },
            {
              "role": "user",
              "content": "Previous generated result didn't pass validation.\n        Reasons:\n        - The OUTPUT incorrectly states that the smallest effective dosage for the patient's DHEA level (5.7 umol/L) is 20 mg, whereas it should correctly be 5 mg, which accommodates levels of 8 umol/L or lower.\n- The statement regarding dosage eligibility overlooks the fact that the 5 mg dosage is suitable even though the patient qualifies for dosages of 20 mg or lower. The faithful output should suggest the smallest suitable dosage, which is 5 mg.\n\n        Regenerate response."
            }
          ]
        }
      },
      {
        "json": {
          "originItem": {
            "name": "Pregnenolone",
            "phase": "Diagnosis confirmed",
            "url": "https://fhir.aera.health/fhir/R4/ActivityDefinition/9f7c5069-9e7b-4ef3-83d0-43caeab6af86",
            "type": "Treatment",
            "symptoms": [
              "Sleep issues",
              "Declining memory concentration and attention",
              "Fatigue",
              "Joint and muscle pain",
              "Decreased sex drive"
            ],
            "objective": "Improve sleep and hormone production",
            "inclusionTrigger": "Sleep issues, stressfull lifestyle, works a lot, competitive environment",
            "exclusionTrigger": "Pregnenolone supplementation should be absolutely avoided in individuals with hormone-sensitive cancers (such as breast, ovarian, uterine, or prostate cancer), as well as in those with conditions like endometriosis or uterine fibroids, due to its potential to influence hormone levels. Pregnant or breastfeeding women should also avoid pregnenolone, as its safety in these populations has not been established. People with bipolar disorder or other severe mental health disorders should avoid pregnenolone, as it may exacerbate mood instability or trigger manic episodes. Those with liver or kidney disease are advised against its use, given the body’s reliance on these organs for metabolizing pregnenolone, which could pose a risk. Finally, pregnenolone should not be taken by individuals on hormone therapies, such as birth control or hormone replacement therapy, due to potential interactions that could disrupt hormone balance.",
            "options": [
              "Capsules",
              "Rapid Disolving Tablets",
              "Lozenges",
              "Sublingual drops"
            ],
            "frequency": "Daily at night",
            "dossingInstructions": "Begin with 50% of optimal dose for first 2 weeks then normal dose, -20% for RDTs, Lozenges & Sublingual Drops",
            "review": "",
            "benefit": "Improve sleep & overall hormonal production",
            "supportingActivities": "Consume foods rich in cholesterol (eggs & lean meats)",
            "description": "Pregnenolone is a steroid hormone involved in the synthesis of other steroids, including DHEA and progesterone. It's administered orally and is thought to improve cognitive performance and memory, relieve symptoms of menopause, and enhance mood.\n\nIndications:\n• Cognitive decline\n• Mood disorders\n• Hormonal imbalances\n\nContraindications:\n• Hormone-sensitive cancers\n• Severe liver or kidney disease\n• History of seizures\n\nPotential Side Effects:\n• Overstimulation and insomnia\n• Mood swings\n• Headaches\n• Irregular heart rhythms",
            "dosages": [
              {
                "dosage": "30mg",
                "inclusionTrigger": "",
                "exclusionTrigger": ""
              },
              {
                "dosage": "50mg",
                "inclusionTrigger": "",
                "exclusionTrigger": ""
              }
            ]
          },
          "matchResult": {
            "isRecommended": true,
            "recommendationReason": "The patient meets the inclusion criteria with symptoms of insomnia and work stress. There are no exclusion criteria conflicts identified.",
            "notRecommendationReason": "",
            "option": "Capsules",
            "dosage": {
              "dosage": "30mg",
              "recommendationReason": "30mg is the smallest effective dosage available, suitable to start with for improving sleep and hormone production objectives."
            }
          },
          "matchedDosage": {
            "dosage": "30mg",
            "inclusionTrigger": "",
            "exclusionTrigger": ""
          },
          "validationResults": [
            {
              "retry": 0,
              "isValid": true,
              "reasons": [
                "The patient has insomnia and work stress, which align with the inclusion criteria of sleep issues and a stressful lifestyle.",
                "The patient does not have any conditions listed in the exclusion criteria.",
                "There is no discrepancy in recommending the initial 30mg dosage of Pregnenolone, considering the absence of exclusion criteria conflicts."
              ]
            }
          ],
          "history": [
            {
              "role": "system",
              "content": "You are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both `inclusionTrigger` and `exclusionTrigger` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as `objective`, `benefit`, `supportingActivities` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the `dosages` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if `options` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n{\"json\":{\"originItem\":{\"name\":\"Pregnenolone\",\"phase\":\"Diagnosis confirmed\",\"url\":\"https://fhir.aera.health/fhir/R4/ActivityDefinition/9f7c5069-9e7b-4ef3-83d0-43caeab6af86\",\"type\":\"Treatment\",\"symptoms\":[\"Sleep issues\",\"Declining memory concentration and attention\",\"Fatigue\",\"Joint and muscle pain\",\"Decreased sex drive\"],\"objective\":\"Improve sleep and hormone production\",\"inclusionTrigger\":\"Sleep issues, stressfull lifestyle, works a lot, competitive environment\",\"exclusionTrigger\":\"Pregnenolone supplementation should be absolutely avoided in individuals with hormone-sensitive cancers (such as breast, ovarian, uterine, or prostate cancer), as well as in those with conditions like endometriosis or uterine fibroids, due to its potential to influence hormone levels. Pregnant or breastfeeding women should also avoid pregnenolone, as its safety in these populations has not been established. People with bipolar disorder or other severe mental health disorders should avoid pregnenolone, as it may exacerbate mood instability or trigger manic episodes. Those with liver or kidney disease are advised against its use, given the body’s reliance on these organs for metabolizing pregnenolone, which could pose a risk. Finally, pregnenolone should not be taken by individuals on hormone therapies, such as birth control or hormone replacement therapy, due to potential interactions that could disrupt hormone balance.\",\"options\":[\"Capsules\",\"Rapid Disolving Tablets\",\"Lozenges\",\"Sublingual drops\"],\"frequency\":\"Daily at night\",\"dossingInstructions\":\"Begin with 50% of optimal dose for first 2 weeks then normal dose, -20% for RDTs, Lozenges & Sublingual Drops\",\"review\":\"\",\"benefit\":\"Improve sleep & overall hormonal production\",\"supportingActivities\":\"Consume foods rich in cholesterol (eggs & lean meats)\",\"description\":\"Pregnenolone is a steroid hormone involved in the synthesis of other steroids, including DHEA and progesterone. It's administered orally and is thought to improve cognitive performance and memory, relieve symptoms of menopause, and enhance mood.\\n\\nIndications:\\n• Cognitive decline\\n• Mood disorders\\n• Hormonal imbalances\\n\\nContraindications:\\n• Hormone-sensitive cancers\\n• Severe liver or kidney disease\\n• History of seizures\\n\\nPotential Side Effects:\\n• Overstimulation and insomnia\\n• Mood swings\\n• Headaches\\n• Irregular heart rhythms\",\"dosages\":[{\"dosage\":\"30mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}]},\"matchResult\":null,\"matchedDosage\":null,\"validationResults\":[],\"history\":[]},\"pairedItem\":{\"item\":2}}"
            },
            {
              "role": "user",
              "content": "### **Patient data:**\n\n# Patient profile\n\n      # Patient profile\r\n\r\n- Age: 58\r\n- DOB: 1966\r\n- Gender: male\r\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\r\n\r\n---\r\n\r\n# Social  \r\n\r\n**Date: 12/02/2020**  \r\n- otherwise well  \r\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \r\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \r\n\r\n**Date: 10/09/2018**  \r\n- Ex-Cigar Smoker  \r\n\r\n**Date: 11/05/2017**  \r\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \r\n- Non-smoker  \r\n- 3-4 times a week  \r\n- 1-2 hours per week  \r\n- company director  \r\n- Smoked for 28 years, 20 a day, 28 pack day history  \r\n- Married  \r\n- Light drinker - 1-2u/day  \r\n\r\n---\r\n\r\n# Medical history  \r\n\r\n**Date: 07/06/2023**  \r\n- Discussed sharing records with NHS practice  \r\n\r\n**Date: 25/03/2023**  \r\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \r\n\r\n**Date: 01/11/2021**  \r\n- Systolic BP: 110  \r\n- Diastolic BP: 72  \r\n\r\n**Date: 10/02/2021**  \r\n- Weight: 90.2  \r\n- BMI: 28.47  \r\n\r\n**Date: 05/12/2020**  \r\n- Blood Pressure: 121.78  \r\n\r\n**Date: 12/02/2020**  \r\n- Height: 178  \r\n\r\n**Date: 10/09/2018**  \r\n- Pulse: 77  \r\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \r\n\r\n**Date: 27/10/2017**  \r\n- Blood Oxygen: 97  \r\n- lungs clear, good a/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \r\n\r\n---\r\n\r\n# Medication  \r\n\r\n**Date: 12/02/2020**  \r\n- Omega 3 and Krill oil\r\n\r\n**Date: 10/09/2018**  \r\n- aspirin 75mg  \r\n\r\n**Date: 05/01/2017**  \r\n- nil  \r\n\r\n---\r\n\r\n# Family history  \r\n\r\n**Date: 10/09/2018**  \r\n- Younger brother recently Dx AF at 47yo  \r\n\r\n**Date: 11/05/2017**  \r\n- Unsure of who father is  \r\n- Mum: 75 years old - OA  \r\n- Has two brothers  \r\n- Brothers have no medical problems  \r\n- Mum has AF  \r\n- Brother-in-law: Prostate cancer  \r\n\r\n---\r\n\r\n# Allergy  \r\n\r\n**Date: 05/01/2017**  \r\n- NKDA\r\n\n\n      ---\n      \n    \n      # Blood test results\n    \n      {\"date\":\"05/06/2023\",\"results\":[{\"test\":\"HAEMOGLOBIN\",\"range\":\"130 - 170\",\"unit\":\"g/L\",\"value\":147},{\"test\":\"HCT\",\"range\":\"0.37 - 0.50\",\"value\":0.448},{\"test\":\"RED CELL COUNT\",\"range\":\"4.40 - 5.80\",\"unit\":\"x10^12/L\",\"value\":4.78},{\"test\":\"MCV\",\"range\":\"80 - 99\",\"unit\":\"fL\",\"value\":93.7},{\"test\":\"MCH\",\"range\":\"27.0 - 33.5\",\"unit\":\"pg\",\"value\":30.8},{\"test\":\"MCHC\",\"range\":\"300 - 350\",\"unit\":\"g/L\",\"value\":328},{\"test\":\"RDW\",\"range\":\"11.5 - 15.0\",\"value\":12},{\"test\":\"PLATELET COUNT\",\"range\":\"150 - 400\",\"unit\":\"x10^9/L\",\"value\":174},{\"test\":\"MPV\",\"range\":\"7 - 13\",\"unit\":\"fL\",\"value\":10.9},{\"test\":\"WHITE CELL COUNT\",\"range\":\"3.0 - 10.0\",\"unit\":\"x10^9/L\",\"value\":5.95},{\"test\":\"Neutrophils\",\"range\":\"2.0 - 7.5\",\"unit\":\"x10^9/L\",\"value\":3.43,\"percentage\":57.6},{\"test\":\"Lymphocytes\",\"range\":\"1.2 - 3.65\",\"unit\":\"x10^9/L\",\"value\":2.02,\"percentage\":33.9},{\"test\":\"Monocytes\",\"range\":\"0.2 - 1.0\",\"unit\":\"x10^9/L\",\"value\":0.44,\"percentage\":7.4},{\"test\":\"Eosinophils\",\"range\":\"0.0 - 0.4\",\"unit\":\"x10^9/L\",\"value\":0.05,\"percentage\":0.8},{\"test\":\"Basophils\",\"range\":\"0.0 - 0.1\",\"unit\":\"x10^9/L\",\"value\":0.02,\"percentage\":0.3},{\"test\":\"ALBUMIN\",\"range\":\"34 - 50\",\"unit\":\"g/L\",\"value\":46},{\"test\":\"Prostate Specific Ag (Total)\",\"range\":\"0.00 - 2.99\",\"unit\":\"ug/L\",\"value\":0.29},{\"test\":\"FOLLICLE STIM. HORMONE\",\"range\":\"1.5 - 12.4\",\"unit\":\"IU/L\",\"value\":3.3},{\"test\":\"LUTEINISING HORMONE\",\"range\":\"1.7 - 8.6\",\"unit\":\"IU/L\",\"value\":2.5},{\"test\":\"PROGESTERONE\",\"range\":\"0.2 - 0.5\",\"unit\":\"nmol/L\",\"value\":0.5},{\"test\":\"TESTOSTERONE\",\"range\":\"7.6 - 31.4\",\"unit\":\"nmol/L\",\"value\":20.8},{\"test\":\"SEX HORMONE BINDING GLOB\",\"range\":\"19 - 83\",\"unit\":\"nmol/L\",\"value\":70},{\"test\":\"PROLACTIN\",\"range\":\"86 - 324\",\"unit\":\"mIU/L\",\"value\":113},{\"test\":\"17-Beta OESTRADIOL\",\"range\":\"< 192\",\"unit\":\"pmol/L\",\"value\":81},{\"test\":\"D.H.E.A. Sulphate\",\"range\":\"0.44 - 13.4\",\"unit\":\"umol/L\",\"value\":5.7},{\"test\":\"Free Testosterone\",\"range\":\"5.0 - 21.0\",\"unit\":\"pg/ml\",\"value\":8.2},{\"test\":\"Dihydrotestosterone\",\"range\":\"0.33 - 3.01\",\"unit\":\"nmol/L\",\"value\":1.61}]}\n\n      ---"
            },
            {
              "role": "assistant",
              "content": "### Evaluation of Medication for the Patient\n\n**Medication Name**: Pregnenolone  \n**Objective**: Improve sleep and hormone production\n\n#### Inclusion Criteria Analysis:\n- **Conditions Required**: Sleep issues, stressful lifestyle, works a lot, competitive environment.\n- **Patient Symptoms and Lifestyle**: \n  - **Insomnia** (Sleep issues) - present.\n  - **Work stress** (Stressful lifestyle, works a lot) - present.\n  - Competitive environment is not explicitly confirmed in the patient data, but the work stress as a company director might indicate this. However, assumption should not be made unless explicitly confirmed.\n\nThe patient meets multiple inclusion criteria, notably the presence of insomnia and work stress.\n\n#### Exclusion Criteria Analysis:\n- **Conditions Required for Exclusion**: \n  - Hormone-sensitive cancers (such as breast, ovarian, uterine, or prostate cancer)\n  - Endometriosis or uterine fibroids \n  - Pregnant or breastfeeding \n  - Bipolar disorder or severe mental health disorders\n  - Liver or kidney disease\n  - Individuals on hormone therapies\n  \n- **Patient Conditions**: \n  - There is no history of hormone-sensitive cancers (PSA levels are within range: 0.29 ug/L).\n  - No mention of endometriosis, uterine fibroids, mental health disorders, or liver/kidney disease.\n  - Patient is male, so pregnancy or breastfeeding does not apply.\n  - No current hormone therapy noted in the medication section.\n\nThe patient does not meet any exclusion criteria.\n\n### Dosage Selection:\n- **Dosages Available**: 30mg, 50mg\n- Nothing specific about dosage criteria excluding the patient for either 30mg or 50mg. Since pregnenolone's supportive goal is to improve sleep and reduce fatigue, starting with the smallest effective dose is generally a recommended approach.\n\n### Options:\n- Patient preferences or history do not specify a preferred drug form; we can recommend starting capsules since they are standard.\n\n### Conclusion:\n- **Medication Suitability**: Pregnenolone is suitable for the patient.\n- **Selected Dosage**: Initiate with **30mg** dosage, as it is the smallest dose and should be effective given the objective to improve sleep and hormone production.\n- **Form**: Capsules due to ease of administration.\n\n**Note**: Start with 50% of the optimal dose for the first two weeks, so **initial dosing will be 15mg per day**. Adjust as per the dosing instructions. Reassess progress and any side effects before considering dosage increase."
            }
          ]
        }
      },
      {
        "json": {
          "originItem": {
            "name": "Nebido injection",
            "phase": "Diagnosis confirmed",
            "url": "",
            "type": "Treatment",
            "symptoms": [
              "Reduced sex drive",
              "Reduced erectile function",
              "Loss of body hair",
              "Less beard growtw",
              "Loss of lean muscle mass",
              "Fatigue",
              "Obesity",
              "Symptoms of depression"
            ],
            "objective": "Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)",
            "inclusionTrigger": "Personal preference: convenience; not need to remember to take daily",
            "exclusionTrigger": "Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions",
            "options": [
              "Injection"
            ],
            "frequency": "First visit, 1 month later, months 3 & 5",
            "dossingInstructions": "",
            "review": "",
            "benefit": "",
            "supportingActivities": "",
            "description": "",
            "dosages": [
              {
                "dosage": "1000mg / 4ml",
                "inclusionTrigger": "",
                "exclusionTrigger": ""
              }
            ]
          },
          "matchResult": {
            "isRecommended": false,
            "notRecommendationReason": "The inclusion criterion of convenience (not needing to remember to take daily) is not explicitly stated in the patient data as a preference. It is uncertain if Nebido is preferred by the patient based on the given criterion.",
            "option": "Injection",
            "dosage": {
              "dosage": "1000mg / 4ml",
              "recommendationReason": "This is the available dosage with no contraindications based on medical data alone, pending verification of patient preference for this form of treatment."
            }
          },
          "matchedDosage": {
            "dosage": "1000mg / 4ml",
            "inclusionTrigger": "",
            "exclusionTrigger": ""
          },
          "validationResults": [
            {
              "retry": 0,
              "isValid": false,
              "reasons": [
                "The evaluation states the inclusion criterion of convenience may be a patient preference, but the patient data does not explicitly confirm this preference. Therefore, the inclusion criterion is not explicitly confirmed, which conflicts with the task's requirement for confirmation.",
                "The conclusion that there are no exclusion criteria conflicts is accurate given the patient's data, but the output's recommendation to consider Nebido based on convenience is not supported by the data as the preference is not explicitly recorded."
              ]
            }
          ],
          "history": [
            {
              "role": "system",
              "content": "You are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both `inclusionTrigger` and `exclusionTrigger` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as `objective`, `benefit`, `supportingActivities` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the `dosages` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if `options` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n{\"json\":{\"originItem\":{\"name\":\"Nebido injection\",\"phase\":\"Diagnosis confirmed\",\"url\":\"\",\"type\":\"Treatment\",\"symptoms\":[\"Reduced sex drive\",\"Reduced erectile function\",\"Loss of body hair\",\"Less beard growtw\",\"Loss of lean muscle mass\",\"Fatigue\",\"Obesity\",\"Symptoms of depression\"],\"objective\":\"Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)\",\"inclusionTrigger\":\"Personal preference: convenience; not need to remember to take daily\",\"exclusionTrigger\":\"Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions\",\"options\":[\"Injection\"],\"frequency\":\"First visit, 1 month later, months 3 & 5\",\"dossingInstructions\":\"\",\"review\":\"\",\"benefit\":\"\",\"supportingActivities\":\"\",\"description\":\"\",\"dosages\":[{\"dosage\":\"1000mg / 4ml\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}]},\"matchResult\":null,\"matchedDosage\":null,\"validationResults\":[],\"history\":[]},\"pairedItem\":{\"item\":3}}"
            },
            {
              "role": "user",
              "content": "### **Patient data:**\n\n# Patient profile\n\n      # Patient profile\r\n\r\n- Age: 58\r\n- DOB: 1966\r\n- Gender: male\r\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\r\n\r\n---\r\n\r\n# Social  \r\n\r\n**Date: 12/02/2020**  \r\n- otherwise well  \r\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \r\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \r\n\r\n**Date: 10/09/2018**  \r\n- Ex-Cigar Smoker  \r\n\r\n**Date: 11/05/2017**  \r\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \r\n- Non-smoker  \r\n- 3-4 times a week  \r\n- 1-2 hours per week  \r\n- company director  \r\n- Smoked for 28 years, 20 a day, 28 pack day history  \r\n- Married  \r\n- Light drinker - 1-2u/day  \r\n\r\n---\r\n\r\n# Medical history  \r\n\r\n**Date: 07/06/2023**  \r\n- Discussed sharing records with NHS practice  \r\n\r\n**Date: 25/03/2023**  \r\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \r\n\r\n**Date: 01/11/2021**  \r\n- Systolic BP: 110  \r\n- Diastolic BP: 72  \r\n\r\n**Date: 10/02/2021**  \r\n- Weight: 90.2  \r\n- BMI: 28.47  \r\n\r\n**Date: 05/12/2020**  \r\n- Blood Pressure: 121.78  \r\n\r\n**Date: 12/02/2020**  \r\n- Height: 178  \r\n\r\n**Date: 10/09/2018**  \r\n- Pulse: 77  \r\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \r\n\r\n**Date: 27/10/2017**  \r\n- Blood Oxygen: 97  \r\n- lungs clear, good a/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \r\n\r\n---\r\n\r\n# Medication  \r\n\r\n**Date: 12/02/2020**  \r\n- Omega 3 and Krill oil\r\n\r\n**Date: 10/09/2018**  \r\n- aspirin 75mg  \r\n\r\n**Date: 05/01/2017**  \r\n- nil  \r\n\r\n---\r\n\r\n# Family history  \r\n\r\n**Date: 10/09/2018**  \r\n- Younger brother recently Dx AF at 47yo  \r\n\r\n**Date: 11/05/2017**  \r\n- Unsure of who father is  \r\n- Mum: 75 years old - OA  \r\n- Has two brothers  \r\n- Brothers have no medical problems  \r\n- Mum has AF  \r\n- Brother-in-law: Prostate cancer  \r\n\r\n---\r\n\r\n# Allergy  \r\n\r\n**Date: 05/01/2017**  \r\n- NKDA\r\n\n\n      ---\n      \n    \n      # Blood test results\n    \n      {\"date\":\"05/06/2023\",\"results\":[{\"test\":\"HAEMOGLOBIN\",\"range\":\"130 - 170\",\"unit\":\"g/L\",\"value\":147},{\"test\":\"HCT\",\"range\":\"0.37 - 0.50\",\"value\":0.448},{\"test\":\"RED CELL COUNT\",\"range\":\"4.40 - 5.80\",\"unit\":\"x10^12/L\",\"value\":4.78},{\"test\":\"MCV\",\"range\":\"80 - 99\",\"unit\":\"fL\",\"value\":93.7},{\"test\":\"MCH\",\"range\":\"27.0 - 33.5\",\"unit\":\"pg\",\"value\":30.8},{\"test\":\"MCHC\",\"range\":\"300 - 350\",\"unit\":\"g/L\",\"value\":328},{\"test\":\"RDW\",\"range\":\"11.5 - 15.0\",\"value\":12},{\"test\":\"PLATELET COUNT\",\"range\":\"150 - 400\",\"unit\":\"x10^9/L\",\"value\":174},{\"test\":\"MPV\",\"range\":\"7 - 13\",\"unit\":\"fL\",\"value\":10.9},{\"test\":\"WHITE CELL COUNT\",\"range\":\"3.0 - 10.0\",\"unit\":\"x10^9/L\",\"value\":5.95},{\"test\":\"Neutrophils\",\"range\":\"2.0 - 7.5\",\"unit\":\"x10^9/L\",\"value\":3.43,\"percentage\":57.6},{\"test\":\"Lymphocytes\",\"range\":\"1.2 - 3.65\",\"unit\":\"x10^9/L\",\"value\":2.02,\"percentage\":33.9},{\"test\":\"Monocytes\",\"range\":\"0.2 - 1.0\",\"unit\":\"x10^9/L\",\"value\":0.44,\"percentage\":7.4},{\"test\":\"Eosinophils\",\"range\":\"0.0 - 0.4\",\"unit\":\"x10^9/L\",\"value\":0.05,\"percentage\":0.8},{\"test\":\"Basophils\",\"range\":\"0.0 - 0.1\",\"unit\":\"x10^9/L\",\"value\":0.02,\"percentage\":0.3},{\"test\":\"ALBUMIN\",\"range\":\"34 - 50\",\"unit\":\"g/L\",\"value\":46},{\"test\":\"Prostate Specific Ag (Total)\",\"range\":\"0.00 - 2.99\",\"unit\":\"ug/L\",\"value\":0.29},{\"test\":\"FOLLICLE STIM. HORMONE\",\"range\":\"1.5 - 12.4\",\"unit\":\"IU/L\",\"value\":3.3},{\"test\":\"LUTEINISING HORMONE\",\"range\":\"1.7 - 8.6\",\"unit\":\"IU/L\",\"value\":2.5},{\"test\":\"PROGESTERONE\",\"range\":\"0.2 - 0.5\",\"unit\":\"nmol/L\",\"value\":0.5},{\"test\":\"TESTOSTERONE\",\"range\":\"7.6 - 31.4\",\"unit\":\"nmol/L\",\"value\":20.8},{\"test\":\"SEX HORMONE BINDING GLOB\",\"range\":\"19 - 83\",\"unit\":\"nmol/L\",\"value\":70},{\"test\":\"PROLACTIN\",\"range\":\"86 - 324\",\"unit\":\"mIU/L\",\"value\":113},{\"test\":\"17-Beta OESTRADIOL\",\"range\":\"< 192\",\"unit\":\"pmol/L\",\"value\":81},{\"test\":\"D.H.E.A. Sulphate\",\"range\":\"0.44 - 13.4\",\"unit\":\"umol/L\",\"value\":5.7},{\"test\":\"Free Testosterone\",\"range\":\"5.0 - 21.0\",\"unit\":\"pg/ml\",\"value\":8.2},{\"test\":\"Dihydrotestosterone\",\"range\":\"0.33 - 3.01\",\"unit\":\"nmol/L\",\"value\":1.61}]}\n\n      ---"
            },
            {
              "role": "assistant",
              "content": "### Evaluation of Medication Criteria for Nebido Injection\n\n**Inclusion Criteria Confirmation:**\n- **Inclusion Trigger:** Convenience and not needing to remember to take daily medication.\n  - **Confirmation:** The inclusion criterion is patient-dependent preference for convenience, and it is not explicitly mentioned in the patient data whether the patient prefers an injection to a daily oral supplement.\n\n**Exclusion Criteria Check:**\n- **Exclusion Trigger:** Avoid usage in men with prostate/male breast cancer, untreated severe sleep apnea, advanced heart failure, very high hematocrit levels, known allergies to testosterone, and caution in those with BPH, elevated PSA levels, heart failure, clotting disorders, or uncontrolled hypertension.\n  - **Prostate Cancer:** The patient's brother-in-law has prostate cancer, but there is no indication that the patient has it (PSA is 0.29 ug/L, which is within the normal range).\n  - **Sleep Apnea, Heart Failure, Hematocrit Levels, Allergies:** No history or medical records indicating these conditions; hematocrit is 0.448 (within normal range).\n  - **Benign Prostatic Hyperplasia (BPH) or Elevated PSA:** PSA level is low at 0.29 ug/L, and no mention of BPH.\n  - **Blood Clotting Disorders or Uncontrolled Hypertension:** No reference to clotting disorders; Blood Pressure on 01/11/2021 was 110/72, which is normal.\n  - **Testosterone Levels:** Free testosterone level is 8.2 pg/ml, which is within the range but not in the optimal therapeutic objective (0.415-0.45 nmol/L or approximately 12-13 pg/ml).\n\n### Determination:\n- **Inclusion Criteria Conclusion:** While the inclusion criterion of convenience may be a patient preference, it is not explicitly stated in the patient data. Thus, it is uncertain if Nebido is preferred by the patient based on the given criterion.\n- **Exclusion Criteria Conclusion:** There are no explicit exclusion criteria conflicts based on the patient data.\n\n### Dosage Selection:\n- **Available Dosage:** 1000mg / 4ml\n  - Given there are no dosage conflicts, and the standard dosage form is available, if chosen, the patient should take this only after more detailed evaluation of preference.\n  \n### Option Selection:\n- **Option:** Injection is the sole available form.\n  \n### Reasoning:\n- The patient's free testosterone levels and lack of explicit contraindicating conditions could allow for the use of Nebido given the inclusion is matched by explicit patient preference for its convenience. As of this data, it is not advisable on medical data alone to initiate treatment without confirmation of patient preference for injection over daily oral intake. \n\n### Recommendation:\nDiscuss the preference for medication administration form with the patient to confirm the inclusion criterion of convenience. If the patient prefers not having a daily regimen, the Nebido Injection 1000mg/4ml may then be considered, following a detailed physician evaluation."
            },
            {
              "role": "user",
              "content": "Previous generated result didn't pass validation.\n        Reasons:\n        - The evaluation states the inclusion criterion of convenience may be a patient preference, but the patient data does not explicitly confirm this preference. Therefore, the inclusion criterion is not explicitly confirmed, which conflicts with the task's requirement for confirmation.\n- The conclusion that there are no exclusion criteria conflicts is accurate given the patient's data, but the output's recommendation to consider Nebido based on convenience is not supported by the data as the preference is not explicitly recorded.\n\n        Regenerate response."
            }
          ]
        }
      },
      {
        "json": {
          "originItem": {
            "name": "Vitamine D",
            "phase": "Diagnosis confirmed",
            "url": "https://fhir.aera.health/fhir/R4/ActivityDefinition/cd33e96f-38fb-487b-9303-56f7ca71686e",
            "type": "Treatment",
            "symptoms": [
              "Persistent fatigue",
              "low energy",
              "muscle weakness",
              "bone density loss",
              "mood disturbances (such as depression and irritability)",
              "compromised immune function",
              "visceral fat accumulation",
              "slow muscle recovery",
              "reduced physical performance"
            ],
            "objective": "Bring Vitamine 25(OH)D to optimal range of 175 nmol/L",
            "inclusionTrigger": "When Vitamine 25(OH)D is lower than 175 nmol/L in healthy men and 200 in men with chronic or autoinmune diseases",
            "exclusionTrigger": "Absolute contraindications for vitamin D supplementation include hypercalcemia, sarcoidosis, tuberculosis, certain lymphomas, severe kidney disease or end-stage renal disease, hypervitaminosis D (vitamin D toxicity), and allergies to vitamin D or its additives.",
            "options": [],
            "frequency": "",
            "dossingInstructions": "",
            "review": "",
            "benefit": "",
            "supportingActivities": "",
            "description": "Vitamin D is essential for bone health, immune function, and reduction of inflammation. It is typically administered orally to correct deficiencies, support bone health, and potentially prevent a range of chronic diseases.\n\nIndications:\n• Vitamin D deficiency\n• Osteoporosis\n• Autoimmune disorders\n• Prevention of certain cancers\n\nContraindications:\n• Hypercalcemia\n• Severe renal disease\n\nPotential Side Effects:\n• Hypercalcemia if overdosed\n• Nausea\n• Fatigue\n• Kidney stones",
            "dosages": [
              {
                "dosage": "4.000UI",
                "option": "Capsule",
                "frequency": "Daily",
                "inclusionTrigger": "",
                "exclusionTrigger": ""
              },
              {
                "dosage": "300.000UI",
                "option": "Vial",
                "frequency": "4 vials every 8 weeks",
                "inclusionTrigger": "",
                "exclusionTrigger": ""
              }
            ]
          },
          "matchResult": {
            "isRecommended": false,
            "notRecommendationReason": "The current laboratory data does not include Vitamin 25(OH)D levels, which is necessary to confirm if the patient meets the inclusion criteria for Vitamin D supplementation.",
            "option": "",
            "dosage": {
              "dosage": "",
              "recommendationReason": ""
            }
          },
          "matchedDosage": null,
          "validationResults": [
            {
              "retry": 0,
              "isValid": true,
              "reasons": [
                "The output correctly identifies that the Vitamin 25(OH)D levels are not present in the current patient data, making it impossible to confirm the inclusion criteria for Vitamin D supplementation.",
                "The output accurately notes the absence of exclusion conditions in the patient's data, such as hypercalcemia or severe kidney disease.",
                "The conclusion provided is appropriate given the lack of necessary Vitamin 25(OH)D level data, and the suggestion to conduct a specific test is a valid recommendation."
              ]
            }
          ],
          "history": [
            {
              "role": "system",
              "content": "You are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both `inclusionTrigger` and `exclusionTrigger` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as `objective`, `benefit`, `supportingActivities` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the `dosages` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if `options` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n{\"json\":{\"originItem\":{\"name\":\"Vitamine D\",\"phase\":\"Diagnosis confirmed\",\"url\":\"https://fhir.aera.health/fhir/R4/ActivityDefinition/cd33e96f-38fb-487b-9303-56f7ca71686e\",\"type\":\"Treatment\",\"symptoms\":[\"Persistent fatigue\",\"low energy\",\"muscle weakness\",\"bone density loss\",\"mood disturbances (such as depression and irritability)\",\"compromised immune function\",\"visceral fat accumulation\",\"slow muscle recovery\",\"reduced physical performance\"],\"objective\":\"Bring Vitamine 25(OH)D to optimal range of 175 nmol/L\",\"inclusionTrigger\":\"When Vitamine 25(OH)D is lower than 175 nmol/L in healthy men and 200 in men with chronic or autoinmune diseases\",\"exclusionTrigger\":\"Absolute contraindications for vitamin D supplementation include hypercalcemia, sarcoidosis, tuberculosis, certain lymphomas, severe kidney disease or end-stage renal disease, hypervitaminosis D (vitamin D toxicity), and allergies to vitamin D or its additives.\",\"options\":[],\"frequency\":\"\",\"dossingInstructions\":\"\",\"review\":\"\",\"benefit\":\"\",\"supportingActivities\":\"\",\"description\":\"Vitamin D is essential for bone health, immune function, and reduction of inflammation. It is typically administered orally to correct deficiencies, support bone health, and potentially prevent a range of chronic diseases.\\n\\nIndications:\\n• Vitamin D deficiency\\n• Osteoporosis\\n• Autoimmune disorders\\n• Prevention of certain cancers\\n\\nContraindications:\\n• Hypercalcemia\\n• Severe renal disease\\n\\nPotential Side Effects:\\n• Hypercalcemia if overdosed\\n• Nausea\\n• Fatigue\\n• Kidney stones\",\"dosages\":[{\"dosage\":\"4.000UI\",\"option\":\"Capsule\",\"frequency\":\"Daily\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"},{\"dosage\":\"300.000UI\",\"option\":\"Vial\",\"frequency\":\"4 vials every 8 weeks\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}]},\"matchResult\":null,\"matchedDosage\":null,\"validationResults\":[],\"history\":[]},\"pairedItem\":{\"item\":4}}"
            },
            {
              "role": "user",
              "content": "### **Patient data:**\n\n# Patient profile\n\n      # Patient profile\r\n\r\n- Age: 58\r\n- DOB: 1966\r\n- Gender: male\r\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\r\n\r\n---\r\n\r\n# Social  \r\n\r\n**Date: 12/02/2020**  \r\n- otherwise well  \r\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \r\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \r\n\r\n**Date: 10/09/2018**  \r\n- Ex-Cigar Smoker  \r\n\r\n**Date: 11/05/2017**  \r\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \r\n- Non-smoker  \r\n- 3-4 times a week  \r\n- 1-2 hours per week  \r\n- company director  \r\n- Smoked for 28 years, 20 a day, 28 pack day history  \r\n- Married  \r\n- Light drinker - 1-2u/day  \r\n\r\n---\r\n\r\n# Medical history  \r\n\r\n**Date: 07/06/2023**  \r\n- Discussed sharing records with NHS practice  \r\n\r\n**Date: 25/03/2023**  \r\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \r\n\r\n**Date: 01/11/2021**  \r\n- Systolic BP: 110  \r\n- Diastolic BP: 72  \r\n\r\n**Date: 10/02/2021**  \r\n- Weight: 90.2  \r\n- BMI: 28.47  \r\n\r\n**Date: 05/12/2020**  \r\n- Blood Pressure: 121.78  \r\n\r\n**Date: 12/02/2020**  \r\n- Height: 178  \r\n\r\n**Date: 10/09/2018**  \r\n- Pulse: 77  \r\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \r\n\r\n**Date: 27/10/2017**  \r\n- Blood Oxygen: 97  \r\n- lungs clear, good a/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \r\n\r\n---\r\n\r\n# Medication  \r\n\r\n**Date: 12/02/2020**  \r\n- Omega 3 and Krill oil\r\n\r\n**Date: 10/09/2018**  \r\n- aspirin 75mg  \r\n\r\n**Date: 05/01/2017**  \r\n- nil  \r\n\r\n---\r\n\r\n# Family history  \r\n\r\n**Date: 10/09/2018**  \r\n- Younger brother recently Dx AF at 47yo  \r\n\r\n**Date: 11/05/2017**  \r\n- Unsure of who father is  \r\n- Mum: 75 years old - OA  \r\n- Has two brothers  \r\n- Brothers have no medical problems  \r\n- Mum has AF  \r\n- Brother-in-law: Prostate cancer  \r\n\r\n---\r\n\r\n# Allergy  \r\n\r\n**Date: 05/01/2017**  \r\n- NKDA\r\n\n\n      ---\n      \n    \n      # Blood test results\n    \n      {\"date\":\"05/06/2023\",\"results\":[{\"test\":\"HAEMOGLOBIN\",\"range\":\"130 - 170\",\"unit\":\"g/L\",\"value\":147},{\"test\":\"HCT\",\"range\":\"0.37 - 0.50\",\"value\":0.448},{\"test\":\"RED CELL COUNT\",\"range\":\"4.40 - 5.80\",\"unit\":\"x10^12/L\",\"value\":4.78},{\"test\":\"MCV\",\"range\":\"80 - 99\",\"unit\":\"fL\",\"value\":93.7},{\"test\":\"MCH\",\"range\":\"27.0 - 33.5\",\"unit\":\"pg\",\"value\":30.8},{\"test\":\"MCHC\",\"range\":\"300 - 350\",\"unit\":\"g/L\",\"value\":328},{\"test\":\"RDW\",\"range\":\"11.5 - 15.0\",\"value\":12},{\"test\":\"PLATELET COUNT\",\"range\":\"150 - 400\",\"unit\":\"x10^9/L\",\"value\":174},{\"test\":\"MPV\",\"range\":\"7 - 13\",\"unit\":\"fL\",\"value\":10.9},{\"test\":\"WHITE CELL COUNT\",\"range\":\"3.0 - 10.0\",\"unit\":\"x10^9/L\",\"value\":5.95},{\"test\":\"Neutrophils\",\"range\":\"2.0 - 7.5\",\"unit\":\"x10^9/L\",\"value\":3.43,\"percentage\":57.6},{\"test\":\"Lymphocytes\",\"range\":\"1.2 - 3.65\",\"unit\":\"x10^9/L\",\"value\":2.02,\"percentage\":33.9},{\"test\":\"Monocytes\",\"range\":\"0.2 - 1.0\",\"unit\":\"x10^9/L\",\"value\":0.44,\"percentage\":7.4},{\"test\":\"Eosinophils\",\"range\":\"0.0 - 0.4\",\"unit\":\"x10^9/L\",\"value\":0.05,\"percentage\":0.8},{\"test\":\"Basophils\",\"range\":\"0.0 - 0.1\",\"unit\":\"x10^9/L\",\"value\":0.02,\"percentage\":0.3},{\"test\":\"ALBUMIN\",\"range\":\"34 - 50\",\"unit\":\"g/L\",\"value\":46},{\"test\":\"Prostate Specific Ag (Total)\",\"range\":\"0.00 - 2.99\",\"unit\":\"ug/L\",\"value\":0.29},{\"test\":\"FOLLICLE STIM. HORMONE\",\"range\":\"1.5 - 12.4\",\"unit\":\"IU/L\",\"value\":3.3},{\"test\":\"LUTEINISING HORMONE\",\"range\":\"1.7 - 8.6\",\"unit\":\"IU/L\",\"value\":2.5},{\"test\":\"PROGESTERONE\",\"range\":\"0.2 - 0.5\",\"unit\":\"nmol/L\",\"value\":0.5},{\"test\":\"TESTOSTERONE\",\"range\":\"7.6 - 31.4\",\"unit\":\"nmol/L\",\"value\":20.8},{\"test\":\"SEX HORMONE BINDING GLOB\",\"range\":\"19 - 83\",\"unit\":\"nmol/L\",\"value\":70},{\"test\":\"PROLACTIN\",\"range\":\"86 - 324\",\"unit\":\"mIU/L\",\"value\":113},{\"test\":\"17-Beta OESTRADIOL\",\"range\":\"< 192\",\"unit\":\"pmol/L\",\"value\":81},{\"test\":\"D.H.E.A. Sulphate\",\"range\":\"0.44 - 13.4\",\"unit\":\"umol/L\",\"value\":5.7},{\"test\":\"Free Testosterone\",\"range\":\"5.0 - 21.0\",\"unit\":\"pg/ml\",\"value\":8.2},{\"test\":\"Dihydrotestosterone\",\"range\":\"0.33 - 3.01\",\"unit\":\"nmol/L\",\"value\":1.61}]}\n\n      ---"
            },
            {
              "role": "assistant",
              "content": "### Evaluation of Vitamin D Suitability and Dosage for the Patient\n\n#### 1. **Evaluate Medication Criteria**\n\n- **Inclusion Criteria:**\n  - The inclusion trigger for vitamin D supplementation is when Vitamin 25(OH)D is lower than 175 nmol/L in healthy men and 200 in men with chronic or autoimmune diseases.\n  - **Current Patient Data:** The current blood test results do not provide information about the Vitamin 25(OH)D level. Therefore, we cannot confirm if the inclusion criteria are met based on available data.\n\n- **Exclusion Criteria:**\n  - The exclusion criteria include conditions like hypercalcemia, sarcoidosis, tuberculosis, certain lymphomas, and severe kidney disease, among others. \n  - **Current Patient Data** do not indicate any of these exclusion conditions. The patient does not have any documented autoimmune or chronic diseases and there is no mention of the exclusion conditions like kidney disease.\n\n#### 2. **Recommendation on Vitamin D Usage:**\n- Due to the lack of specific Vitamin 25(OH)D levels in the patient's current blood test results, there's insufficient information to confirm whether the inclusion criteria are met for Vitamin D supplementation. \n\n#### 3. **Dosage Selection**\n- Since the inclusion criteria cannot be confirmed, selecting a dosage without Vitamin 25(OH)D levels would not be appropriate. Thus, the decision is to not recommend a specific dosage at this time.\n\n#### Conclusion:\n- The recommendation to apply Vitamin D cannot be confirmed due to missing laboratory results specifically detailing the Vitamin 25(OH)D levels. It’s advisable to conduct a specific test for Vitamin 25(OH)D to ascertain whether supplementation is necessary and identify the appropriate dosage if required."
            }
          ]
        }
      },
      {
        "json": {
          "originItem": {
            "name": "Anastrozole",
            "phase": "Diagnosis confirmed",
            "url": "https://fhir.aera.health/fhir/R4/ActivityDefinition/f444b1bd-938b-4e16-8739-0cc7a7e2acb1",
            "type": "Treatment",
            "symptoms": [
              "Gynecomastia & Obesity",
              "lack of confidence"
            ],
            "objective": "Help reduce weight and improve mood",
            "inclusionTrigger": "Gynecomastia & Obesity, lack of confidence",
            "exclusionTrigger": "",
            "options": [
              "Capsule"
            ],
            "frequency": "Daily during 6 weeks, then every two days during 6 weeks",
            "dossingInstructions": "",
            "review": "",
            "benefit": "",
            "supportingActivities": "",
            "description": "Anastrozole is an aromatase inhibitor used primarily to treat breast cancer in postmenopausal women. It works by lowering estrogen hormone levels to help shrink tumors and slow tumor growth. Anastrozole is taken orally.\n\nIndications:\n• Breast cancer in postmenopausal women\n• Adjuvant treatment of early breast cancer\n• First-line treatment of locally advanced or metastatic breast cancer\n\nContraindications:\n• Pre-existing heart conditions\n• Osteoporosis\n• Pre-menopausal women\n\nPotential Side Effects:\n• Increased risk of fractures\n• Joint pain\n• Nausea\n• Weakness",
            "dosages": [
              {
                "dosage": "1mg",
                "inclusionTrigger": "",
                "exclusionTrigger": ""
              }
            ]
          },
          "matchResult": {
            "isRecommended": false,
            "notRecommendationReason": "The medication Anastrozole should not be applied to the patient since the inclusion criteria of gynecomastia and obesity with lack of confidence are not met based on the available data. The patient's symptoms do not align with the required conditions for this medication.",
            "option": "",
            "dosage": {
              "dosage": "N/A",
              "recommendationReason": "Not applicable as the medication is not recommended."
            }
          },
          "validationResults": [
            {
              "retry": 0,
              "isValid": true,
              "reasons": [
                "The inclusion criteria for Anastrozole require the presence of 'Gynecomastia & Obesity' and 'lack of confidence.' The patient data does not indicate gynecomastia or obesity, only a BMI of 28.47 which categorizes him as overweight, not obese.",
                "Symptoms described in the patient profile include insomnia, fatigue, afternoon tiredness, lower energy levels, and work stress, which do not align with the inclusion criteria for Anastrozole.",
                "Exclusion criteria for Anastrozole do not apply to this patient. He does not have pre-existing heart conditions or osteoporosis, and he is not pre-menopausal or female.",
                "Without confirmation of the specific inclusion criteria symptoms, Anastrozole should not be recommended for this patient.",
                "As the inclusion criteria are not satisfied, the selection of dosage and consideration of medication form (capsule) for Anastrozole is irrelevant."
              ]
            }
          ],
          "history": [
            {
              "role": "system",
              "content": "You are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both `inclusionTrigger` and `exclusionTrigger` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as `objective`, `benefit`, `supportingActivities` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the `dosages` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if `options` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n{\"json\":{\"originItem\":{\"name\":\"Anastrozole\",\"phase\":\"Diagnosis confirmed\",\"url\":\"https://fhir.aera.health/fhir/R4/ActivityDefinition/f444b1bd-938b-4e16-8739-0cc7a7e2acb1\",\"type\":\"Treatment\",\"symptoms\":[\"Gynecomastia & Obesity\",\"lack of confidence\"],\"objective\":\"Help reduce weight and improve mood\",\"inclusionTrigger\":\"Gynecomastia & Obesity, lack of confidence\",\"exclusionTrigger\":\"\",\"options\":[\"Capsule\"],\"frequency\":\"Daily during 6 weeks, then every two days during 6 weeks\",\"dossingInstructions\":\"\",\"review\":\"\",\"benefit\":\"\",\"supportingActivities\":\"\",\"description\":\"Anastrozole is an aromatase inhibitor used primarily to treat breast cancer in postmenopausal women. It works by lowering estrogen hormone levels to help shrink tumors and slow tumor growth. Anastrozole is taken orally.\\n\\nIndications:\\n• Breast cancer in postmenopausal women\\n• Adjuvant treatment of early breast cancer\\n• First-line treatment of locally advanced or metastatic breast cancer\\n\\nContraindications:\\n• Pre-existing heart conditions\\n• Osteoporosis\\n• Pre-menopausal women\\n\\nPotential Side Effects:\\n• Increased risk of fractures\\n• Joint pain\\n• Nausea\\n• Weakness\",\"dosages\":[{\"dosage\":\"1mg\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}]},\"matchResult\":null,\"matchedDosage\":null,\"validationResults\":[],\"history\":[]},\"pairedItem\":{\"item\":5}}"
            },
            {
              "role": "user",
              "content": "### **Patient data:**\n\n# Patient profile\n\n      # Patient profile\r\n\r\n- Age: 58\r\n- DOB: 1966\r\n- Gender: male\r\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\r\n\r\n---\r\n\r\n# Social  \r\n\r\n**Date: 12/02/2020**  \r\n- otherwise well  \r\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \r\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \r\n\r\n**Date: 10/09/2018**  \r\n- Ex-Cigar Smoker  \r\n\r\n**Date: 11/05/2017**  \r\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \r\n- Non-smoker  \r\n- 3-4 times a week  \r\n- 1-2 hours per week  \r\n- company director  \r\n- Smoked for 28 years, 20 a day, 28 pack day history  \r\n- Married  \r\n- Light drinker - 1-2u/day  \r\n\r\n---\r\n\r\n# Medical history  \r\n\r\n**Date: 07/06/2023**  \r\n- Discussed sharing records with NHS practice  \r\n\r\n**Date: 25/03/2023**  \r\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \r\n\r\n**Date: 01/11/2021**  \r\n- Systolic BP: 110  \r\n- Diastolic BP: 72  \r\n\r\n**Date: 10/02/2021**  \r\n- Weight: 90.2  \r\n- BMI: 28.47  \r\n\r\n**Date: 05/12/2020**  \r\n- Blood Pressure: 121.78  \r\n\r\n**Date: 12/02/2020**  \r\n- Height: 178  \r\n\r\n**Date: 10/09/2018**  \r\n- Pulse: 77  \r\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \r\n\r\n**Date: 27/10/2017**  \r\n- Blood Oxygen: 97  \r\n- lungs clear, good a/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \r\n\r\n---\r\n\r\n# Medication  \r\n\r\n**Date: 12/02/2020**  \r\n- Omega 3 and Krill oil\r\n\r\n**Date: 10/09/2018**  \r\n- aspirin 75mg  \r\n\r\n**Date: 05/01/2017**  \r\n- nil  \r\n\r\n---\r\n\r\n# Family history  \r\n\r\n**Date: 10/09/2018**  \r\n- Younger brother recently Dx AF at 47yo  \r\n\r\n**Date: 11/05/2017**  \r\n- Unsure of who father is  \r\n- Mum: 75 years old - OA  \r\n- Has two brothers  \r\n- Brothers have no medical problems  \r\n- Mum has AF  \r\n- Brother-in-law: Prostate cancer  \r\n\r\n---\r\n\r\n# Allergy  \r\n\r\n**Date: 05/01/2017**  \r\n- NKDA\r\n\n\n      ---\n      \n    \n      # Blood test results\n    \n      {\"date\":\"05/06/2023\",\"results\":[{\"test\":\"HAEMOGLOBIN\",\"range\":\"130 - 170\",\"unit\":\"g/L\",\"value\":147},{\"test\":\"HCT\",\"range\":\"0.37 - 0.50\",\"value\":0.448},{\"test\":\"RED CELL COUNT\",\"range\":\"4.40 - 5.80\",\"unit\":\"x10^12/L\",\"value\":4.78},{\"test\":\"MCV\",\"range\":\"80 - 99\",\"unit\":\"fL\",\"value\":93.7},{\"test\":\"MCH\",\"range\":\"27.0 - 33.5\",\"unit\":\"pg\",\"value\":30.8},{\"test\":\"MCHC\",\"range\":\"300 - 350\",\"unit\":\"g/L\",\"value\":328},{\"test\":\"RDW\",\"range\":\"11.5 - 15.0\",\"value\":12},{\"test\":\"PLATELET COUNT\",\"range\":\"150 - 400\",\"unit\":\"x10^9/L\",\"value\":174},{\"test\":\"MPV\",\"range\":\"7 - 13\",\"unit\":\"fL\",\"value\":10.9},{\"test\":\"WHITE CELL COUNT\",\"range\":\"3.0 - 10.0\",\"unit\":\"x10^9/L\",\"value\":5.95},{\"test\":\"Neutrophils\",\"range\":\"2.0 - 7.5\",\"unit\":\"x10^9/L\",\"value\":3.43,\"percentage\":57.6},{\"test\":\"Lymphocytes\",\"range\":\"1.2 - 3.65\",\"unit\":\"x10^9/L\",\"value\":2.02,\"percentage\":33.9},{\"test\":\"Monocytes\",\"range\":\"0.2 - 1.0\",\"unit\":\"x10^9/L\",\"value\":0.44,\"percentage\":7.4},{\"test\":\"Eosinophils\",\"range\":\"0.0 - 0.4\",\"unit\":\"x10^9/L\",\"value\":0.05,\"percentage\":0.8},{\"test\":\"Basophils\",\"range\":\"0.0 - 0.1\",\"unit\":\"x10^9/L\",\"value\":0.02,\"percentage\":0.3},{\"test\":\"ALBUMIN\",\"range\":\"34 - 50\",\"unit\":\"g/L\",\"value\":46},{\"test\":\"Prostate Specific Ag (Total)\",\"range\":\"0.00 - 2.99\",\"unit\":\"ug/L\",\"value\":0.29},{\"test\":\"FOLLICLE STIM. HORMONE\",\"range\":\"1.5 - 12.4\",\"unit\":\"IU/L\",\"value\":3.3},{\"test\":\"LUTEINISING HORMONE\",\"range\":\"1.7 - 8.6\",\"unit\":\"IU/L\",\"value\":2.5},{\"test\":\"PROGESTERONE\",\"range\":\"0.2 - 0.5\",\"unit\":\"nmol/L\",\"value\":0.5},{\"test\":\"TESTOSTERONE\",\"range\":\"7.6 - 31.4\",\"unit\":\"nmol/L\",\"value\":20.8},{\"test\":\"SEX HORMONE BINDING GLOB\",\"range\":\"19 - 83\",\"unit\":\"nmol/L\",\"value\":70},{\"test\":\"PROLACTIN\",\"range\":\"86 - 324\",\"unit\":\"mIU/L\",\"value\":113},{\"test\":\"17-Beta OESTRADIOL\",\"range\":\"< 192\",\"unit\":\"pmol/L\",\"value\":81},{\"test\":\"D.H.E.A. Sulphate\",\"range\":\"0.44 - 13.4\",\"unit\":\"umol/L\",\"value\":5.7},{\"test\":\"Free Testosterone\",\"range\":\"5.0 - 21.0\",\"unit\":\"pg/ml\",\"value\":8.2},{\"test\":\"Dihydrotestosterone\",\"range\":\"0.33 - 3.01\",\"unit\":\"nmol/L\",\"value\":1.61}]}\n\n      ---"
            },
            {
              "role": "assistant",
              "content": "**Evaluation of Medication Criteria:**\n\n1. **Inclusion Criteria Confirmation:**\n\n   - The medication Anastrozole is indicated for patients with symptoms of gynecomastia and obesity, and a lack of confidence. \n   - In the patient data provided, there is no mention of gynecomastia or obesity. The patient has symptoms of insomnia, fatigue, afternoon tiredness, lower energy levels, and work stress.\n   - The patient's BMI is 28.47 (Date: 10/02/2021), indicating overweight but not classified explicitly in the patient's records as obesity.\n   - Therefore, the inclusion criteria (\"Gynecomastia & Obesity, lack of confidence\") are not explicitly confirmed based on the available patient data.\n\n2. **Exclusion Criteria Confirmation:**\n\n   - Anastrozole exclusion criteria include pre-existing heart conditions, osteoporosis, pre-menopausal women. \n   - The patient is a 58-year-old male, so the criteria regarding pre-menopausal women do not apply.\n   - There are no indications of pre-existing heart conditions or osteoporosis in the medical history that would contraindicate the use of this medication.\n\n**Decision:**\n\n- The medication Anastrozole should not be applied to the patient since the inclusion criteria are not met based on the available data of symptoms and medical history. \n\n- There are no matching inclusion conditions for the use of Anastrozole in this patient's profile, so selecting an effective dosage is not applicable. \n\n- The option to administer Anastrozole as a \"Capsule\" is irrelevant, as the criteria for use are not satisfied.\n\n**Conclusion:**\n\n- The recommendation for Anastrozole cannot be supported due to the absence of confirmed symptoms aligning with the inclusion criteria. Therefore, no dosage or form of this medication should be considered for the current patient case."
            }
          ]
        }
      }
    ],
    "Match and Validate Try  1": [
      {
        "json": {
          "originItem": {
            "name": "DHEA",
            "phase": "Diagnosis confirmed",
            "url": "https://fhir.aera.health/fhir/R4/ActivityDefinition/e03cdbbf-b2e8-437a-a0e0-3bf1d302dffe",
            "type": "Treatment",
            "symptoms": [
              "Obesity",
              "Erectile disfunction",
              "Adrenal insuficiency"
            ],
            "objective": "Bring DHEA sulphate levels to an optimal range (6umol/L)",
            "inclusionTrigger": "",
            "exclusionTrigger": "DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.",
            "options": [
              "Capsules",
              "Rapid Disolving Tablets",
              "Lozenges",
              "Sublingual drops"
            ],
            "frequency": "Daily at 7:00 AM",
            "dossingInstructions": "Begin with 50% of optimal dose for first 2 weeks afterwards normal dose, -20% for RDTs, Lozenges & Sublingual Drops",
            "review": "3 months",
            "benefit": "",
            "supportingActivities": "",
            "description": "Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress. DHEA is administered orally.\n\nIndications:\n• Adrenal insufficiency\n• Depression\n• Systemic lupus erythematosus (SLE)\n• Aging skin\n\nContraindications:\n• Cancer of the breast, ovaries, or prostate\n• Severe liver disease\n• Pregnancy\n\nPotential Side Effects:\n• Oily skin and acne\n• Hair loss\n• Stomach upset\n• High blood pressure",
            "dosages": [
              {
                "dosage": "5mg",
                "inclusionTrigger": "When DHEA measurements are around 8umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "10mg",
                "inclusionTrigger": "When DHEA measurements are around 7umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "15mg",
                "inclusionTrigger": "When DHEA measurements are around 6umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "20mg",
                "inclusionTrigger": "When DHEA measurements are around 5umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "30mg",
                "inclusionTrigger": "When DHEA measurements are around 4umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "35mg",
                "inclusionTrigger": "When DHEA measurements are around 3umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "45mg",
                "inclusionTrigger": "When DHEA measurements are around 2umol/L or lower",
                "exclusionTrigger": ""
              },
              {
                "dosage": "50mg",
                "inclusionTrigger": "When DHEA measurements are around 1umol/L or lower",
                "exclusionTrigger": ""
              }
            ]
          },
          "matchResult": {
            "isRecommended": true,
            "recommendationReason": "The patient's DHEA sulphate level is 5.7 umol/L which qualifies for a dosage, and there are no exclusion criteria observed in the patient's medical history or current health status.",
            "notRecommendationReason": "",
            "option": "Capsules",
            "dosage": {
              "dosage": "5 mg",
              "recommendationReason": "The smallest effective dosage is 5 mg as it accommodates DHEA levels around 8 umol/L or lower, and the current level is 5.7 umol/L."
            }
          },
          "validationResults": [
            {
              "retry": 0,
              "isValid": false,
              "reasons": [
                "The OUTPUT incorrectly states that the smallest effective dosage for the patient's DHEA level (5.7 umol/L) is 20 mg, whereas it should correctly be 5 mg, which accommodates levels of 8 umol/L or lower.",
                "The statement regarding dosage eligibility overlooks the fact that the 5 mg dosage is suitable even though the patient qualifies for dosages of 20 mg or lower. The faithful output should suggest the smallest suitable dosage, which is 5 mg."
              ]
            },
            {
              "retry": 1,
              "isValid": true,
              "reasons": [
                "The patient's DHEA Sulphate level of 5.7 umol/L is confirmed to fall within the 8 umol/L or lower range, qualifying for the smallest dosage of DHEA, which is 5 mg.",
                "There are no contradictions in the exclusion criteria based on the given patient data. The patient does not exhibit any conditions that would contraindicate the use of DHEA.",
                "The selection of the smallest effective dosage of 5 mg is faithful to the patient's current health metrics and matches the medication dosage criteria provided."
              ]
            }
          ],
          "history": [
            {
              "role": "system",
              "content": "You are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both `inclusionTrigger` and `exclusionTrigger` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as `objective`, `benefit`, `supportingActivities` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the `dosages` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if `options` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n{\"json\":{\"originItem\":{\"name\":\"DHEA\",\"phase\":\"Diagnosis confirmed\",\"url\":\"https://fhir.aera.health/fhir/R4/ActivityDefinition/e03cdbbf-b2e8-437a-a0e0-3bf1d302dffe\",\"type\":\"Treatment\",\"symptoms\":[\"Obesity\",\"Erectile disfunction\",\"Adrenal insuficiency\"],\"objective\":\"Bring DHEA sulphate levels to an optimal range (6umol/L)\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"DHEA supplementation may be contraindicated in cases of hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or if taking certain medications.\",\"options\":[\"Capsules\",\"Rapid Disolving Tablets\",\"Lozenges\",\"Sublingual drops\"],\"frequency\":\"Daily at 7:00 AM\",\"dossingInstructions\":\"Begin with 50% of optimal dose for first 2 weeks afterwards normal dose, -20% for RDTs, Lozenges & Sublingual Drops\",\"review\":\"3 months\",\"benefit\":\"\",\"supportingActivities\":\"\",\"description\":\"Dehydroepiandrosterone (DHEA) supplementation is used to increase DHEA and DHEA-sulfate levels in the body, potentially enhancing energy, strength, immune function, and decreasing stress. DHEA is administered orally.\\n\\nIndications:\\n• Adrenal insufficiency\\n• Depression\\n• Systemic lupus erythematosus (SLE)\\n• Aging skin\\n\\nContraindications:\\n• Cancer of the breast, ovaries, or prostate\\n• Severe liver disease\\n• Pregnancy\\n\\nPotential Side Effects:\\n• Oily skin and acne\\n• Hair loss\\n• Stomach upset\\n• High blood pressure\",\"dosages\":[{\"dosage\":\"5mg\",\"inclusionTrigger\":\"When DHEA measurements are around 8umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"10mg\",\"inclusionTrigger\":\"When DHEA measurements are around 7umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"15mg\",\"inclusionTrigger\":\"When DHEA measurements are around 6umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"20mg\",\"inclusionTrigger\":\"When DHEA measurements are around 5umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"30mg\",\"inclusionTrigger\":\"When DHEA measurements are around 4umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"35mg\",\"inclusionTrigger\":\"When DHEA measurements are around 3umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"45mg\",\"inclusionTrigger\":\"When DHEA measurements are around 2umol/L or lower\",\"exclusionTrigger\":\"\"},{\"dosage\":\"50mg\",\"inclusionTrigger\":\"When DHEA measurements are around 1umol/L or lower\",\"exclusionTrigger\":\"\"}]},\"matchResult\":null,\"matchedDosage\":null,\"validationResults\":[],\"history\":[]},\"pairedItem\":{\"item\":1}}"
            },
            {
              "role": "user",
              "content": "### **Patient data:**\n\n# Patient profile\n\n      # Patient profile\r\n\r\n- Age: 58\r\n- DOB: 1966\r\n- Gender: male\r\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\r\n\r\n---\r\n\r\n# Social  \r\n\r\n**Date: 12/02/2020**  \r\n- otherwise well  \r\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \r\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \r\n\r\n**Date: 10/09/2018**  \r\n- Ex-Cigar Smoker  \r\n\r\n**Date: 11/05/2017**  \r\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \r\n- Non-smoker  \r\n- 3-4 times a week  \r\n- 1-2 hours per week  \r\n- company director  \r\n- Smoked for 28 years, 20 a day, 28 pack day history  \r\n- Married  \r\n- Light drinker - 1-2u/day  \r\n\r\n---\r\n\r\n# Medical history  \r\n\r\n**Date: 07/06/2023**  \r\n- Discussed sharing records with NHS practice  \r\n\r\n**Date: 25/03/2023**  \r\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \r\n\r\n**Date: 01/11/2021**  \r\n- Systolic BP: 110  \r\n- Diastolic BP: 72  \r\n\r\n**Date: 10/02/2021**  \r\n- Weight: 90.2  \r\n- BMI: 28.47  \r\n\r\n**Date: 05/12/2020**  \r\n- Blood Pressure: 121.78  \r\n\r\n**Date: 12/02/2020**  \r\n- Height: 178  \r\n\r\n**Date: 10/09/2018**  \r\n- Pulse: 77  \r\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \r\n\r\n**Date: 27/10/2017**  \r\n- Blood Oxygen: 97  \r\n- lungs clear, good a/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \r\n\r\n---\r\n\r\n# Medication  \r\n\r\n**Date: 12/02/2020**  \r\n- Omega 3 and Krill oil\r\n\r\n**Date: 10/09/2018**  \r\n- aspirin 75mg  \r\n\r\n**Date: 05/01/2017**  \r\n- nil  \r\n\r\n---\r\n\r\n# Family history  \r\n\r\n**Date: 10/09/2018**  \r\n- Younger brother recently Dx AF at 47yo  \r\n\r\n**Date: 11/05/2017**  \r\n- Unsure of who father is  \r\n- Mum: 75 years old - OA  \r\n- Has two brothers  \r\n- Brothers have no medical problems  \r\n- Mum has AF  \r\n- Brother-in-law: Prostate cancer  \r\n\r\n---\r\n\r\n# Allergy  \r\n\r\n**Date: 05/01/2017**  \r\n- NKDA\r\n\n\n      ---\n      \n    \n      # Blood test results\n    \n      {\"date\":\"05/06/2023\",\"results\":[{\"test\":\"HAEMOGLOBIN\",\"range\":\"130 - 170\",\"unit\":\"g/L\",\"value\":147},{\"test\":\"HCT\",\"range\":\"0.37 - 0.50\",\"value\":0.448},{\"test\":\"RED CELL COUNT\",\"range\":\"4.40 - 5.80\",\"unit\":\"x10^12/L\",\"value\":4.78},{\"test\":\"MCV\",\"range\":\"80 - 99\",\"unit\":\"fL\",\"value\":93.7},{\"test\":\"MCH\",\"range\":\"27.0 - 33.5\",\"unit\":\"pg\",\"value\":30.8},{\"test\":\"MCHC\",\"range\":\"300 - 350\",\"unit\":\"g/L\",\"value\":328},{\"test\":\"RDW\",\"range\":\"11.5 - 15.0\",\"value\":12},{\"test\":\"PLATELET COUNT\",\"range\":\"150 - 400\",\"unit\":\"x10^9/L\",\"value\":174},{\"test\":\"MPV\",\"range\":\"7 - 13\",\"unit\":\"fL\",\"value\":10.9},{\"test\":\"WHITE CELL COUNT\",\"range\":\"3.0 - 10.0\",\"unit\":\"x10^9/L\",\"value\":5.95},{\"test\":\"Neutrophils\",\"range\":\"2.0 - 7.5\",\"unit\":\"x10^9/L\",\"value\":3.43,\"percentage\":57.6},{\"test\":\"Lymphocytes\",\"range\":\"1.2 - 3.65\",\"unit\":\"x10^9/L\",\"value\":2.02,\"percentage\":33.9},{\"test\":\"Monocytes\",\"range\":\"0.2 - 1.0\",\"unit\":\"x10^9/L\",\"value\":0.44,\"percentage\":7.4},{\"test\":\"Eosinophils\",\"range\":\"0.0 - 0.4\",\"unit\":\"x10^9/L\",\"value\":0.05,\"percentage\":0.8},{\"test\":\"Basophils\",\"range\":\"0.0 - 0.1\",\"unit\":\"x10^9/L\",\"value\":0.02,\"percentage\":0.3},{\"test\":\"ALBUMIN\",\"range\":\"34 - 50\",\"unit\":\"g/L\",\"value\":46},{\"test\":\"Prostate Specific Ag (Total)\",\"range\":\"0.00 - 2.99\",\"unit\":\"ug/L\",\"value\":0.29},{\"test\":\"FOLLICLE STIM. HORMONE\",\"range\":\"1.5 - 12.4\",\"unit\":\"IU/L\",\"value\":3.3},{\"test\":\"LUTEINISING HORMONE\",\"range\":\"1.7 - 8.6\",\"unit\":\"IU/L\",\"value\":2.5},{\"test\":\"PROGESTERONE\",\"range\":\"0.2 - 0.5\",\"unit\":\"nmol/L\",\"value\":0.5},{\"test\":\"TESTOSTERONE\",\"range\":\"7.6 - 31.4\",\"unit\":\"nmol/L\",\"value\":20.8},{\"test\":\"SEX HORMONE BINDING GLOB\",\"range\":\"19 - 83\",\"unit\":\"nmol/L\",\"value\":70},{\"test\":\"PROLACTIN\",\"range\":\"86 - 324\",\"unit\":\"mIU/L\",\"value\":113},{\"test\":\"17-Beta OESTRADIOL\",\"range\":\"< 192\",\"unit\":\"pmol/L\",\"value\":81},{\"test\":\"D.H.E.A. Sulphate\",\"range\":\"0.44 - 13.4\",\"unit\":\"umol/L\",\"value\":5.7},{\"test\":\"Free Testosterone\",\"range\":\"5.0 - 21.0\",\"unit\":\"pg/ml\",\"value\":8.2},{\"test\":\"Dihydrotestosterone\",\"range\":\"0.33 - 3.01\",\"unit\":\"nmol/L\",\"value\":1.61}]}\n\n      ---"
            },
            {
              "role": "assistant",
              "content": "### Evaluation of Medication Criteria for DHEA Supplementation\n\n**Patient's Inclusion Criteria Confirmation:**\n\n1. **DHEA Sulphate Level:**\n   - **Current Level:** 5.7 umol/L \n   - **Inclusion Triggers:** Patients with measurements around 8 umol/L or lower are eligible for dosages. This patient qualifies for dosages at least until 20 mg since his DHEA level (5.7 umol/L) meets criteria up to 20 mg.\n\n**Exclusion Criteria Check:**\n\n- The exclusion criteria include hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or certain medications.\n- **Review of Patient's Data:**\n  - No evidence of hormone-sensitive cancers from the medical history.\n  - No indication of mood disorders or liver/kidney disease. Blood test results support normal organ function.\n  - The blood pressure readings (110/72 mmHg and 121/78 mmHg) are within normal ranges, ruling out hypertension.\n  - No medical history indicating PCOS, adrenal issues, diabetes, or related contraindicating medications.\n\n### Dosage Selection\n\n- **Eligible Dosages Based on Current DHEA Level (5.7 umol/L):**\n  - 5 mg, 10 mg, 15 mg, 20 mg.\n- **Smallest Effective Dosage:** The smallest effective dosage for the current DHEA level is 20 mg, as this dosage directly addresses levels around 5 umol/L or lower.\n\n### Medication Option and Form Selection\n\n- **Options Available:** Capsules, Rapid Dissolving Tablets (RDTs), Lozenges, Sublingual drops\n- **Form Decision:**\n  - Preferences based on convenience or patient preference for administration can guide the choice among available forms.\n  - **Suggested Form:** Capsules - a common form and potentially more acceptable given the wide use.\n\nBased on the assessment, the suitable dosage is **20 mg** with the **Capsule** form as a standard option unless otherwise directed by patient preference. This dosage aligns with the necessity to maintain DHEA levels at an optimal range without exceeding contraindicating thresholds."
            },
            {
              "role": "user",
              "content": "Previous generated result didn't pass validation.\n        Reasons:\n        - The OUTPUT incorrectly states that the smallest effective dosage for the patient's DHEA level (5.7 umol/L) is 20 mg, whereas it should correctly be 5 mg, which accommodates levels of 8 umol/L or lower.\n- The statement regarding dosage eligibility overlooks the fact that the 5 mg dosage is suitable even though the patient qualifies for dosages of 20 mg or lower. The faithful output should suggest the smallest suitable dosage, which is 5 mg.\n\n        Regenerate response."
            },
            {
              "role": "assistant",
              "content": "### Evaluation of Medication Criteria for DHEA Supplementation\n\n**Patient's Inclusion Criteria Confirmation:**\n\n1. **DHEA Sulphate Level:**\n   - **Current Level:** 5.7 umol/L \n   - **Inclusion Triggers:** Patients with measurements around 8 umol/L or lower are eligible for dosages. This patient qualifies for the smallest dosage since his DHEA level (5.7 umol/L) meets all criteria for dosages up to 8 umol/L.\n\n**Exclusion Criteria Check:**\n\n- The exclusion criteria include hormone-sensitive cancers, high baseline DHEA, PCOS, pregnancy, mood disorders, liver or kidney disease, adrenal issues, diabetes, high blood pressure, or certain medications.\n- **Review of Patient's Data:**\n  - No evidence of hormone-sensitive cancers from the medical history.\n  - No indication of mood disorders or liver/kidney disease. Blood test results support normal organ function.\n  - The blood pressure readings (110/72 mmHg and 121/78 mmHg) are within normal ranges, ruling out hypertension.\n  - No medical history indicating PCOS, adrenal issues, diabetes, or related contraindicating medications.\n\n### Dosage Selection\n\n- **Eligible Dosages Based on Current DHEA Level (5.7 umol/L):**\n  - 5 mg, 10 mg, 15 mg, 20 mg.\n- **Smallest Effective Dosage:** The smallest effective dosage for the current DHEA level is 5 mg, as this dosage accommodates levels around 8 umol/L or lower.\n\n### Medication Option and Form Selection\n\n- **Options Available:** Capsules, Rapid Dissolving Tablets (RDTs), Lozenges, Sublingual drops\n- **Form Decision:**\n  - Preferences based on convenience or patient preference for administration can guide the choice among available forms.\n  - **Suggested Form:** Capsules - a common form and potentially more acceptable given the wide use.\n\nBased on the assessment, the suitable dosage is **5 mg** with the **Capsule** form as a standard option unless otherwise directed by patient preference. This dosage aligns with maintaining DHEA levels at an optimal range without exceeding contraindicating thresholds."
            }
          ]
        }
      },
      {
        "json": {
          "originItem": {
            "name": "Nebido injection",
            "phase": "Diagnosis confirmed",
            "url": "",
            "type": "Treatment",
            "symptoms": [
              "Reduced sex drive",
              "Reduced erectile function",
              "Loss of body hair",
              "Less beard growtw",
              "Loss of lean muscle mass",
              "Fatigue",
              "Obesity",
              "Symptoms of depression"
            ],
            "objective": "Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)",
            "inclusionTrigger": "Personal preference: convenience; not need to remember to take daily",
            "exclusionTrigger": "Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions",
            "options": [
              "Injection"
            ],
            "frequency": "First visit, 1 month later, months 3 & 5",
            "dossingInstructions": "",
            "review": "",
            "benefit": "",
            "supportingActivities": "",
            "description": "",
            "dosages": [
              {
                "dosage": "1000mg / 4ml",
                "inclusionTrigger": "",
                "exclusionTrigger": ""
              }
            ]
          },
          "matchResult": {
            "isRecommended": false,
            "recommendationReason": "",
            "notRecommendationReason": "The necessary inclusion criteria of confirmed patient preference for the convenience of non-daily medication are unmet. The patient data does not explicitly confirm a preference for the convenience of an injection over daily medication.",
            "option": "Injection",
            "dosage": {
              "dosage": "1000mg / 4ml",
              "recommendationReason": "Due to the lack of confirmed inclusion criteria, this dosage cannot be recommended at this time."
            }
          },
          "matchedDosage": {
            "dosage": "1000mg / 4ml",
            "inclusionTrigger": "",
            "exclusionTrigger": ""
          },
          "validationResults": [
            {
              "retry": 0,
              "isValid": false,
              "reasons": [
                "The evaluation states the inclusion criterion of convenience may be a patient preference, but the patient data does not explicitly confirm this preference. Therefore, the inclusion criterion is not explicitly confirmed, which conflicts with the task's requirement for confirmation.",
                "The conclusion that there are no exclusion criteria conflicts is accurate given the patient's data, but the output's recommendation to consider Nebido based on convenience is not supported by the data as the preference is not explicitly recorded."
              ]
            },
            {
              "retry": 1,
              "isValid": true,
              "reasons": [
                "The output states that the inclusion criterion is not met since the preference for convenience is not explicitly confirmed in the patient data, which is faithful to the context.",
                "The exclusion criteria are accurately assessed with no identified conflicts based on the provided data.",
                "The dosage selection conclusion is appropriate as it indicates the dosage should not be recommended without confirmed inclusion criteria.",
                "The recommendation to not administer Nebido Injection without confirmed patient preference aligns with the evaluation outcome of inclusion and exclusion criteria.",
                "Overall, the output does not introduce any new information and stays true to the context provided."
              ]
            }
          ],
          "history": [
            {
              "role": "system",
              "content": "You are a preventive medicine doctor assistant. Your task is to determine if a medication should be applied to a patient based on patient data and select the appropriate dosage.\n\nTo complete this task:\n\n1. **Evaluate Medication Criteria**: \n - Review both `inclusionTrigger` and `exclusionTrigger` conditions in the medication. \n - Match these conditions to the patient's data, considering all available information in their medical profile, history, and lab results.\n - **Inclusion Criteria Confirmation**. Ensure inclusion criteria are explicitly confirmed by available patient data; do not infer or assume patient conditions.\n - Ensure exclusion criteria do not conflict for the medication to be recommended.\n - Consider reviewing other properties such as `objective`, `benefit`, `supportingActivities` and other properties when reasoning and making decision.\n\n2. **Select Dosage**: After confirming the medication is suitable:\n - Review the `dosages` list to find the smallest effective dosage that meets the inclusion criteria for the patient’s condition without conflicting with any exclusion criteria.\n - If no dosage matches without conflicts, indicate this in the response.\n\n3. **Select option**: Review patient or doctor preferences and choose medication option (form) if `options` are specified.\n\n4. **Provide reasoning with citations on patient data.** Examples of reasoning:\n - The patient's blood pressure is reported as normal in their lab results (Lab Result: \"BP\" Measurement: \"120/80 mmHg\"), and there are no indications of hypertension in their medical history. The inclusion criterion for elevated blood pressure is not met.\n - **Current DHEA Level:** 5.5 umol/L - this qualifies for the dosages where DHEA levels are 6 umol/L or lower. **15 mg DHEA** is the smallest dosage option that addresses the current DHEA level requirement (6 umol/L or lower).\n\n**Medication data**:\n\n{\"json\":{\"originItem\":{\"name\":\"Nebido injection\",\"phase\":\"Diagnosis confirmed\",\"url\":\"\",\"type\":\"Treatment\",\"symptoms\":[\"Reduced sex drive\",\"Reduced erectile function\",\"Loss of body hair\",\"Less beard growtw\",\"Loss of lean muscle mass\",\"Fatigue\",\"Obesity\",\"Symptoms of depression\"],\"objective\":\"Bring Free Testosterone level to an optimal range (0,415-0,45 nmol/L)\",\"inclusionTrigger\":\"Personal preference: convenience; not need to remember to take daily\",\"exclusionTrigger\":\"Testosterone supplementation should be strictly avoided in men with prostate or male breast cancer, severe untreated sleep apnea, advanced heart failure, very high hematocrit levels, or known allergies to testosterone formulations, as these conditions carry serious health risks when combined with hormone therapy. Caution and close monitoring are also essential for those with benign prostatic hyperplasia (BPH), elevated PSA levels, mild to moderate heart failure, blood clotting disorders, or uncontrolled hypertension, as testosterone can exacerbate symptoms or elevate risks associated with these conditions\",\"options\":[\"Injection\"],\"frequency\":\"First visit, 1 month later, months 3 & 5\",\"dossingInstructions\":\"\",\"review\":\"\",\"benefit\":\"\",\"supportingActivities\":\"\",\"description\":\"\",\"dosages\":[{\"dosage\":\"1000mg / 4ml\",\"inclusionTrigger\":\"\",\"exclusionTrigger\":\"\"}]},\"matchResult\":null,\"matchedDosage\":null,\"validationResults\":[],\"history\":[]},\"pairedItem\":{\"item\":3}}"
            },
            {
              "role": "user",
              "content": "### **Patient data:**\n\n# Patient profile\n\n      # Patient profile\r\n\r\n- Age: 58\r\n- DOB: 1966\r\n- Gender: male\r\n- Symptoms: Insomnia, fatigue, afternoon tiredness, lower energy levels, work stress\r\n\r\n---\r\n\r\n# Social  \r\n\r\n**Date: 12/02/2020**  \r\n- otherwise well  \r\n- 40-50 press-ups 2-3 x weekly, Personal trainer weekly, run with the dog 1 time a week - 5k, Golf occasionally, walks to and from station - 2km each way - 4x weekly, rugby training on Sundays with son - but less as son broke ankle 6 months ago (12 years old)  \r\n- Eats 3x a day, healthy. Son is vegan, so more towards vegetarian  \r\n\r\n**Date: 10/09/2018**  \r\n- Ex-Cigar Smoker  \r\n\r\n**Date: 11/05/2017**  \r\n- Last Nov opticians - astigmatisim, left eye weaker than right, has glasses but doesn't wear it. Last saw dentist Jan 2017, sees dentist 6 monthly.  \r\n- Non-smoker  \r\n- 3-4 times a week  \r\n- 1-2 hours per week  \r\n- company director  \r\n- Smoked for 28 years, 20 a day, 28 pack day history  \r\n- Married  \r\n- Light drinker - 1-2u/day  \r\n\r\n---\r\n\r\n# Medical history  \r\n\r\n**Date: 07/06/2023**  \r\n- Discussed sharing records with NHS practice  \r\n\r\n**Date: 25/03/2023**  \r\n- Generally well. CAJCOLD+ left medial collar bone: 5mmx3mm irregularly bordered papule. Uniform hypopigmented colour. No central depression, no flaking, no other sinister characteristics.  \r\n\r\n**Date: 01/11/2021**  \r\n- Systolic BP: 110  \r\n- Diastolic BP: 72  \r\n\r\n**Date: 10/02/2021**  \r\n- Weight: 90.2  \r\n- BMI: 28.47  \r\n\r\n**Date: 05/12/2020**  \r\n- Blood Pressure: 121.78  \r\n\r\n**Date: 12/02/2020**  \r\n- Height: 178  \r\n\r\n**Date: 10/09/2018**  \r\n- Pulse: 77  \r\n- well chest clear GAEB PR regular sats 98%, PR 77 bpm, glands NAD, good colour CRT <2 seconds  \r\n\r\n**Date: 27/10/2017**  \r\n- Blood Oxygen: 97  \r\n- lungs clear, good a/e, abdo soft non tender, bs normal, no organomegaly, well hydrated, HS 1 and 2, and nil else  \r\n\r\n---\r\n\r\n# Medication  \r\n\r\n**Date: 12/02/2020**  \r\n- Omega 3 and Krill oil\r\n\r\n**Date: 10/09/2018**  \r\n- aspirin 75mg  \r\n\r\n**Date: 05/01/2017**  \r\n- nil  \r\n\r\n---\r\n\r\n# Family history  \r\n\r\n**Date: 10/09/2018**  \r\n- Younger brother recently Dx AF at 47yo  \r\n\r\n**Date: 11/05/2017**  \r\n- Unsure of who father is  \r\n- Mum: 75 years old - OA  \r\n- Has two brothers  \r\n- Brothers have no medical problems  \r\n- Mum has AF  \r\n- Brother-in-law: Prostate cancer  \r\n\r\n---\r\n\r\n# Allergy  \r\n\r\n**Date: 05/01/2017**  \r\n- NKDA\r\n\n\n      ---\n      \n    \n      # Blood test results\n    \n      {\"date\":\"05/06/2023\",\"results\":[{\"test\":\"HAEMOGLOBIN\",\"range\":\"130 - 170\",\"unit\":\"g/L\",\"value\":147},{\"test\":\"HCT\",\"range\":\"0.37 - 0.50\",\"value\":0.448},{\"test\":\"RED CELL COUNT\",\"range\":\"4.40 - 5.80\",\"unit\":\"x10^12/L\",\"value\":4.78},{\"test\":\"MCV\",\"range\":\"80 - 99\",\"unit\":\"fL\",\"value\":93.7},{\"test\":\"MCH\",\"range\":\"27.0 - 33.5\",\"unit\":\"pg\",\"value\":30.8},{\"test\":\"MCHC\",\"range\":\"300 - 350\",\"unit\":\"g/L\",\"value\":328},{\"test\":\"RDW\",\"range\":\"11.5 - 15.0\",\"value\":12},{\"test\":\"PLATELET COUNT\",\"range\":\"150 - 400\",\"unit\":\"x10^9/L\",\"value\":174},{\"test\":\"MPV\",\"range\":\"7 - 13\",\"unit\":\"fL\",\"value\":10.9},{\"test\":\"WHITE CELL COUNT\",\"range\":\"3.0 - 10.0\",\"unit\":\"x10^9/L\",\"value\":5.95},{\"test\":\"Neutrophils\",\"range\":\"2.0 - 7.5\",\"unit\":\"x10^9/L\",\"value\":3.43,\"percentage\":57.6},{\"test\":\"Lymphocytes\",\"range\":\"1.2 - 3.65\",\"unit\":\"x10^9/L\",\"value\":2.02,\"percentage\":33.9},{\"test\":\"Monocytes\",\"range\":\"0.2 - 1.0\",\"unit\":\"x10^9/L\",\"value\":0.44,\"percentage\":7.4},{\"test\":\"Eosinophils\",\"range\":\"0.0 - 0.4\",\"unit\":\"x10^9/L\",\"value\":0.05,\"percentage\":0.8},{\"test\":\"Basophils\",\"range\":\"0.0 - 0.1\",\"unit\":\"x10^9/L\",\"value\":0.02,\"percentage\":0.3},{\"test\":\"ALBUMIN\",\"range\":\"34 - 50\",\"unit\":\"g/L\",\"value\":46},{\"test\":\"Prostate Specific Ag (Total)\",\"range\":\"0.00 - 2.99\",\"unit\":\"ug/L\",\"value\":0.29},{\"test\":\"FOLLICLE STIM. HORMONE\",\"range\":\"1.5 - 12.4\",\"unit\":\"IU/L\",\"value\":3.3},{\"test\":\"LUTEINISING HORMONE\",\"range\":\"1.7 - 8.6\",\"unit\":\"IU/L\",\"value\":2.5},{\"test\":\"PROGESTERONE\",\"range\":\"0.2 - 0.5\",\"unit\":\"nmol/L\",\"value\":0.5},{\"test\":\"TESTOSTERONE\",\"range\":\"7.6 - 31.4\",\"unit\":\"nmol/L\",\"value\":20.8},{\"test\":\"SEX HORMONE BINDING GLOB\",\"range\":\"19 - 83\",\"unit\":\"nmol/L\",\"value\":70},{\"test\":\"PROLACTIN\",\"range\":\"86 - 324\",\"unit\":\"mIU/L\",\"value\":113},{\"test\":\"17-Beta OESTRADIOL\",\"range\":\"< 192\",\"unit\":\"pmol/L\",\"value\":81},{\"test\":\"D.H.E.A. Sulphate\",\"range\":\"0.44 - 13.4\",\"unit\":\"umol/L\",\"value\":5.7},{\"test\":\"Free Testosterone\",\"range\":\"5.0 - 21.0\",\"unit\":\"pg/ml\",\"value\":8.2},{\"test\":\"Dihydrotestosterone\",\"range\":\"0.33 - 3.01\",\"unit\":\"nmol/L\",\"value\":1.61}]}\n\n      ---"
            },
            {
              "role": "assistant",
              "content": "### Evaluation of Medication Criteria for Nebido Injection\n\n**Inclusion Criteria Confirmation:**\n- **Inclusion Trigger:** Convenience and not needing to remember to take daily medication.\n  - **Confirmation:** The inclusion criterion is patient-dependent preference for convenience, and it is not explicitly mentioned in the patient data whether the patient prefers an injection to a daily oral supplement.\n\n**Exclusion Criteria Check:**\n- **Exclusion Trigger:** Avoid usage in men with prostate/male breast cancer, untreated severe sleep apnea, advanced heart failure, very high hematocrit levels, known allergies to testosterone, and caution in those with BPH, elevated PSA levels, heart failure, clotting disorders, or uncontrolled hypertension.\n  - **Prostate Cancer:** The patient's brother-in-law has prostate cancer, but there is no indication that the patient has it (PSA is 0.29 ug/L, which is within the normal range).\n  - **Sleep Apnea, Heart Failure, Hematocrit Levels, Allergies:** No history or medical records indicating these conditions; hematocrit is 0.448 (within normal range).\n  - **Benign Prostatic Hyperplasia (BPH) or Elevated PSA:** PSA level is low at 0.29 ug/L, and no mention of BPH.\n  - **Blood Clotting Disorders or Uncontrolled Hypertension:** No reference to clotting disorders; Blood Pressure on 01/11/2021 was 110/72, which is normal.\n  - **Testosterone Levels:** Free testosterone level is 8.2 pg/ml, which is within the range but not in the optimal therapeutic objective (0.415-0.45 nmol/L or approximately 12-13 pg/ml).\n\n### Determination:\n- **Inclusion Criteria Conclusion:** While the inclusion criterion of convenience may be a patient preference, it is not explicitly stated in the patient data. Thus, it is uncertain if Nebido is preferred by the patient based on the given criterion.\n- **Exclusion Criteria Conclusion:** There are no explicit exclusion criteria conflicts based on the patient data.\n\n### Dosage Selection:\n- **Available Dosage:** 1000mg / 4ml\n  - Given there are no dosage conflicts, and the standard dosage form is available, if chosen, the patient should take this only after more detailed evaluation of preference.\n  \n### Option Selection:\n- **Option:** Injection is the sole available form.\n  \n### Reasoning:\n- The patient's free testosterone levels and lack of explicit contraindicating conditions could allow for the use of Nebido given the inclusion is matched by explicit patient preference for its convenience. As of this data, it is not advisable on medical data alone to initiate treatment without confirmation of patient preference for injection over daily oral intake. \n\n### Recommendation:\nDiscuss the preference for medication administration form with the patient to confirm the inclusion criterion of convenience. If the patient prefers not having a daily regimen, the Nebido Injection 1000mg/4ml may then be considered, following a detailed physician evaluation."
            },
            {
              "role": "user",
              "content": "Previous generated result didn't pass validation.\n        Reasons:\n        - The evaluation states the inclusion criterion of convenience may be a patient preference, but the patient data does not explicitly confirm this preference. Therefore, the inclusion criterion is not explicitly confirmed, which conflicts with the task's requirement for confirmation.\n- The conclusion that there are no exclusion criteria conflicts is accurate given the patient's data, but the output's recommendation to consider Nebido based on convenience is not supported by the data as the preference is not explicitly recorded.\n\n        Regenerate response."
            },
            {
              "role": "assistant",
              "content": "### Evaluation of Medication Criteria for Nebido Injection\n\n**Inclusion Criteria Confirmation:**\n- **Inclusion Trigger:** Personal preference for convenience and not needing to remember to take daily medication.\n  - **Confirmation:** The patient data does not explicitly confirm a preference for the convenience of an injection over a daily medication regimen. As a result, we cannot confirm the inclusion criteria based on available data.\n\n**Exclusion Criteria Check:**\n- **Exclusion Trigger:** Avoid usage in men with prostate/male breast cancer, untreated severe sleep apnea, advanced heart failure, very high hematocrit levels, known allergies to testosterone, and caution in those with BPH, elevated PSA levels, heart failure, clotting disorders, or uncontrolled hypertension.\n  - **Prostate/Male Breast Cancer:** The patient has no diagnosed prostate cancer. PSA level is 0.29 ug/L, which is within the normal range. There are no indications or diagnosis of male breast cancer.\n  - **Severe Untreated Sleep Apnea, Advanced Heart Failure, Very High Hematocrit Levels, Allergies to Testosterone:** No such conditions are indicated in the patient's records. Hematocrit level is 0.448, within the normal range.\n  - **Benign Prostatic Hyperplasia (BPH), Elevated PSA Levels, Heart Failure, Blood Clotting Disorders, Uncontrolled Hypertension:** No reported BPH, PSA is low, no evidence of heart failure or clotting disorders. Systolic BP recorded as 110 mmHg and Diastolic BP as 72 mmHg, indicating normal blood pressure.\n\n**Conclusion:**\n- **Inclusion Criteria:** Not met, due to lack of explicit patient preference confirmation for injection convenience.\n- **Exclusion Criteria:** No conflicts; however, initiation of Nebido injection cannot be justified without confirmed inclusion criteria.\n\n### Dosage Selection:\n- The available dosage is 1000mg / 4ml; however, due to the lack of confirmed inclusion criteria, this dosage cannot be recommended at this time.\n\n### Option Selection:\n- **Option Available:** Injection is the only form available.\n\n### Recommendation:\nThe Nebido injection should not be administered at this point, as the necessary inclusion criteria of confirmed patient preference for non-daily medication are unmet. The physician should engage with the patient to determine medication preference explicitly. If convenience of an injection is preferred, further consideration for use may be warranted with physician consultation."
            }
          ]
        }
      }
    ]
  },
  "connections": {
    "Generate patient anamnesis": {
      "main": [
        [
          {
            "node": "Search Health Plan Template",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Search Health Plan Template": {
      "main": [
        [
          {
            "node": "If",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "If": {
      "main": [
        [
          {
            "node": "Download pathway",
            "type": "main",
            "index": 0
          }
        ],
        [
          {
            "node": "Stop and Error",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Download pathway": {
      "main": [
        [
          {
            "node": "Extract Pathway from File",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Extract Pathway from File": {
      "main": [
        [
          {
            "node": "Switch filter interventions",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Match intervention by searched name": {
      "main": [
        [
          {
            "node": "Check filtered result",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Check filtered result": {
      "main": [
        [
          {
            "node": "Map results to final object",
            "type": "main",
            "index": 0
          }
        ],
        [
          {
            "node": "Stop and Error2",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Map results to final object": {
      "main": [
        [
          {
            "node": "Prepare initial prompts",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Prepare initial prompts": {
      "main": [
        [
          {
            "node": "Match and Validate Try 0",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Format response": {
      "main": [
        [
          {
            "node": "Convert to JSON File",
            "type": "main",
            "index": 0
          },
          {
            "node": "Format health plan markdown",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Format health plan markdown": {
      "main": [
        [
          {
            "node": "Convert to MD file",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Merge": {
      "main": [
        [
          {
            "node": "Google Drive",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Google Drive": {
      "main": [
        [
          {
            "node": "Output",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Input data": {
      "main": [
        [
          {
            "node": "Config",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Switch filter interventions": {
      "main": [
        [
          {
            "node": "Match intervention by searched name",
            "type": "main",
            "index": 0
          }
        ],
        [
          {
            "node": "Get all interventions",
            "type": "main",
            "index": 0
          }
        ],
        [
          {
            "node": "Get all interventions",
            "type": "main",
            "index": 0
          }
        ],
        [
          {
            "node": "Prepare prompt for RAG queries generation",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Get all interventions": {
      "main": [
        [
          {
            "node": "Map results to final object",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Execute Workflow Trigger": {
      "main": [
        []
      ]
    },
    "Convert to JSON File": {
      "main": [
        [
          {
            "node": "Merge",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Convert to MD file": {
      "main": [
        [
          {
            "node": "Merge",
            "type": "main",
            "index": 1
          }
        ]
      ]
    },
    "Mock data": {
      "main": [
        [
          {
            "node": "Input data",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Debug trigger": {
      "main": [
        []
      ]
    },
    "OpenAI Chat Model1": {
      "ai_languageModel": [
        [
          {
            "node": "Generate RAG search queries",
            "type": "ai_languageModel",
            "index": 0
          }
        ]
      ]
    },
    "Generate RAG search queries": {
      "main": [
        [
          {
            "node": "Format as JSON",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Prepare prompt for RAG queries generation": {
      "main": [
        [
          {
            "node": "Generate RAG search queries",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "OpenAI Chat Model2": {
      "ai_languageModel": [
        [
          {
            "node": "Format as JSON",
            "type": "ai_languageModel",
            "index": 0
          }
        ]
      ]
    },
    "Structured Output Parser1": {
      "ai_outputParser": [
        [
          {
            "node": "Format as JSON",
            "type": "ai_outputParser",
            "index": 0
          }
        ]
      ]
    },
    "Format as JSON": {
      "main": [
        [
          {
            "node": "Split Out",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Split Out": {
      "main": [
        [
          {
            "node": "Search Intervention Items",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Config": {
      "main": [
        [
          {
            "node": "Generate patient anamnesis",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Search Intervention Items": {
      "main": [
        [
          {
            "node": "If no results",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "If no results": {
      "main": [
        [
          {
            "node": "No Operation, do nothing",
            "type": "main",
            "index": 0
          }
        ],
        [
          {
            "node": "Prefilter and limit interventions by search results",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Map to interventions": {
      "main": [
        [
          {
            "node": "Map results to final object",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Prefilter and limit interventions by search results": {
      "main": [
        [
          {
            "node": "Map to interventions",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Check if match result is valid (final)": {
      "main": [
        [
          {
            "node": "Merge final results",
            "type": "main",
            "index": 0
          }
        ],
        [
          {
            "node": "Map invalid results as not matched",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Map invalid results as not matched": {
      "main": [
        [
          {
            "node": "Merge final results",
            "type": "main",
            "index": 1
          }
        ]
      ]
    },
    "Merge final results": {
      "main": [
        [
          {
            "node": "Format response",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Match and Validate Try 0": {
      "main": [
        [
          {
            "node": "Results after try 0",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Results after try 0": {
      "main": [
        [
          {
            "node": "Check if last result is valid 0",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Match and Validate Try  1": {
      "main": [
        [
          {
            "node": "Results after try 1",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Results after try 1": {
      "main": [
        [
          {
            "node": "Merge1",
            "type": "main",
            "index": 1
          }
        ]
      ]
    },
    "Merge1": {
      "main": [
        [
          {
            "node": "Check if match result is valid (final)",
            "type": "main",
            "index": 0
          }
        ]
      ]
    },
    "Check if last result is valid 0": {
      "main": [
        [
          {
            "node": "Merge1",
            "type": "main",
            "index": 0
          }
        ],
        [
          {
            "node": "Match and Validate Try  1",
            "type": "main",
            "index": 0
          }
        ]
      ]
    }
  },
  "active": false,
  "settings": {
    "executionOrder": "v1"
  },
  "versionId": "55b54a78-9f26-447e-a6cf-8a09f9ef41fa",
  "meta": {
    "instanceId": "558d88703fb65b2d0e44613bc35916258b0f0bf983c5d4730c00c424b77ca36a"
  },
  "id": "FlTNy7Ck4cdbyZoi",
  "tags": []
}